49 results on '"Ganem F"'
Search Results
2. Liver Transplantation Using Chagas-Infected Donors in Uninfected Recipients: A Single-Center Experience Without Prophylactic Therapy
- Author
-
McCormack, L., Quiñónez, E., Goldaracena, N., Anders, M., Rodríguez, V., Orozco Ganem, F., and Mastai, R.C.
- Published
- 2012
- Full Text
- View/download PDF
3. Extremely Marginal Liver Grafts From Deceased Donors Have Outcome Similar to Ideal Grafts
- Author
-
Goldaracena, N., Quiñonez, E., Méndez, P., Anders, M., Orozco Ganem, F., Mastai, R., and McCormack, L.
- Published
- 2012
- Full Text
- View/download PDF
4. LIVER TRANSPLANTATION WITHOUT PERIOPERATIVE TRANSFUSIONS: SINGLE-CENTER EXPERIENCE SHOWING BETTER EARLY OUTCOME AND SHORTER HOSPITAL STAY: BF108
- Author
-
McCormack, L., Goldaracena, N., Quiñonez, E., Méndez, P., Jeanes, C., Ganem, F. O., Anders, M., and Mastai, R.
- Published
- 2012
5. Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10
- Author
-
Tanno, L. K., Ganem, F., Demoly, P., Toscano, C. M., and Bierrenbach, A. L.
- Published
- 2012
- Full Text
- View/download PDF
6. CANCER DISEASE IN THE EMERGENCY DEPARTMENT AND ITS IMPACT ON HOSPITALIZATION AND LENGTH OF STAY
- Author
-
Gil Jr, L.A., primary, Curiati, P.K., additional, Curiati, J.A., additional, Morinaga, C.V., additional, Ganem, F., additional, Cabral, K.N., additional, Olivieri, F.C., additional, Sasdelli, R., additional, Braga, J.L., additional, Correa, F.G., additional, Margarido, B.C., additional, and Silva, T.J.Avelino, additional
- Published
- 2019
- Full Text
- View/download PDF
7. USE OF "MINIMAL" POSTEROLATERAL ARTHRODESIS IN THE DEGERNERATIVE LUMBAR SPINE
- Author
-
GANEM, F, HANSEN, F, and ADAM, Y
- Published
- 1999
8. Meningioma of the third ventricle: Computed tomography and magnetic resonance imaging
- Author
-
de la Sayette, V., Rivaton, F., Chapon, F., Hubert, P., Ganem, F., and Houtteville, J. P.
- Published
- 1991
- Full Text
- View/download PDF
9. Diretrizes brasileiras de antiagregantes plaquetários e anticoagulantes em cardiologia
- Author
-
Valdir Ambrósio Moisés, Fernando Bacal, Montenegro Ce, Montera Mw, Castro I, Jose C. Nicolau, Lorga Filho Am, Montenegro St, Portal Vl, Macq Lopes, Ramos Ai, Carisi Anne Polanczyk, Tsv Jardim, Faria Neto, Ferreira Ac, Simão Af, F Darrieux, Elbio Antonio D'Amico, Leopoldo S. Piegas, Silva Ee, Fenelon G, Sociedade Brasileira de Cardiologia, Flávio Tarasoutchi, Gagliardi Rj, Leite Re, Moraes Neto Fr, Dikran Armaganijan, Heinisch Rh, Esporcatte R, Mvb Malachias, Flávio de Souza Brito, Timerman A, PC Yu, Iran Gonçalves, Correa Filho H, Danielle Menosi Gualandro, Melo Cc, Luciano Moreira Baracioli, Greco Ai, Pinho C, AD Azmus, Antonio Eduardo Pesaro, A Franci, Evaristo Ef, Gomes Fl, Leandro Ioschpe Zimerman, Andrade, Renato A. K. Kalil, Franco Ra, Scudeler Tl, Clausell No, Gaz Mv, Marques Ac, Renato D. Lopes, Luiz Alberto Mattos, Pedro Beraldo de Andrade, Acs Sousa, Joyce M. Annichino-Bizzacchi, de Paola Aa, Alexandre Schaan de Quadros, Fábio Fernandes, Pires Lj, Caramelli B, Machado Neto Ea, Calderaro D, Alves Rc, Atié J, Magalhães Lp, Accorsi Ta, Carlos V. Serrano, Lavítola Pl, D A R Moreira, Ganem F, João Fernando Monteiro Ferreira, Barbosa Mr, Soeiro Am, Edison F. Paiva, Bocchi Ea, Pedro Silvio Farsky, Lemos Neto Pa, GR Morais, Gilson Soares Feitosa, Lopes As, Bacellar Ms, Rrcv Giraldez, LB Silva, R. F. Ramos, Márcio Jansen de Oliveira Figueiredo, Souza Neto Jd, L. A. F. Lisboa, Manica Al, Oscar Pereira Dutra, FR Mattos, A Volschan, Kalil Filho R, Alvaro Avezum, Otávio Rizzi Coelho, Cjdg Barbosa, BA Mendes, Edson Stefanini, and Alves Br
- Subjects
medicine.medical_specialty ,lcsh:Diseases of the circulatory (Cardiovascular) system ,Platelet Antiaggregants ,business.industry ,lcsh:RC666-701 ,Internal medicine ,Cardiology ,medicine ,Cardiology and Cardiovascular Medicine ,business - Published
- 2013
10. P3682Early oral betablocker utilization reduces in-hospital mortality in patients submitted to primary percutaneous coronary intervention: a real-world analysis
- Author
-
Furtado, R.H.M., primary, Dalcoquio, T.F., additional, Nakashima, C.A.K., additional, Scanavini Filho, M.A., additional, Pereira, C.A.C., additional, Lara, L.M., additional, Ganem, F., additional, Giraldez, R.R.C.V., additional, Franken, M., additional, Kalil Filho, R., additional, and Nicolau, J.C., additional
- Published
- 2017
- Full Text
- View/download PDF
11. Vorapaxar in the secondary prevention of atherothrombotic events
- Author
-
Braunwald E, Morrow DA, Scirica BM, Bonaca MP, McCabe CH, Morin S, Fish P, Lamp J, Gershman E, Murphy S, Deenadayalu N, Skene A, Hill K, Bennett L, Strony J, Plat F, Berman G, Lipka L, Kilian A, He W, Liu X, Fox KA, Aylward P, Bassand JP, Betriu A, Bounameaux H, Corbalan R, Creager M, Dalby A, De Ferrari G, Dellborg M, Diehm CH, Dietz R, Goto S, Grande P, Gurbel P, Hankey G, Isaza D, Jensen P, Kiss R, Lewis B, Merlini P, Moliterno D, Morais J, Nicolau JC, Nieminen M, Nilsen D, Olin J, Ophuis TO, Paolasso E, Pichler M, Shinohara Y, Spinar J, Teal P, Tendera M, Theroux P, Thomassen L, Van de Werf F, White H, Wilcox R, Alberts M, Ameriso S, Diener H, Mohr J, Welch M, Wiviott SD, Awtry E, Berger C, Desai A, Gelfand E, Ho C, Leeman D, Link M, Norden A, Pande A, Rost N, Ruberg R, Silverman S, Singhal A, Vita J, Frye RL, Bailey KR, Easton J, Hochman J, Steg PG, Verheught F, Lee K, Mauro DO, Centurion A, Carlevaro O, Cardozo E, Cartasegna L, Soccini N, Farras HA, Molina Aguirre E, Duronto E, Arrechavala L, Rey R, Stilman A, Fernández H, Marinsalta G, Tartaglione J, Chekherdemian M, Povedano G, Casares E, Kantor P, Reges P, Cuneo C, Martinez G, MacKinnon I, Bagnato B, Fernandez A, Funosas C, Lozada A, Barilati P, Ferrari J, Ferrari N, Llanos J, Casaccia G, Giannaula R, García Méndez C, Cirio J, García Dávila C, Estol C, Chiezzo D, Ramirez J, Garrido S, López M, Hominal M, Bianchini MV, Ramos M, Verdini E, Herrera G, Monne H, Ioli P, Samudio MA, Rotta Escalante R, Tarulla A, Reich E, Perez G, Milesi R, Berli M, Marino J, Funes I, Prado A, Bezi M, Fernandez R, Rojas M, Cimbaro Canella JP, Galarza Salazan M, Chew D, Horsfall L, Claxton A, French J, O'Brien K, Nelson G, Loxton A, McCann A, Downey C, Aroney C, Cleave P, Worthley S, Roach A, Amerena J, Long A, Thompson P, Ferguson L, Fitzpatrick M, Mackenzie M, Youssef G, Goldsmith H, Jayasinghe R, Quinlan S, Arstall M, Rose J, Counsell J, Martin M, Crimmins D, Slattery A, Anderson C, Paraskevaidis T, Davis S, Silver G, Gerraty RP, Gapper J, Donnan G, Petrolo S, Whelan A, Tulloch G, Singh B, Campo Ma, Dick R, Savage C, Hill A, Conway B, Waites J, Keays P, Kopp K, Hainzer D, Podczeck Schweighofer A, Priesnitz T, Drexel H, Hagspiel V, Foeger B, Hilbe C, Trinka E, Sinadinoska D, Pilger E, Brodmann M, Stöllberger C, Jungbauer LV, Koppensteiner R, Hoke M, Grisold W, Berger O, Gaul GB, Fazekas N, Wandaller C, Stockenhuber F, Rek A, Willeit J, Zangerle A, Kiechl S, Sturm W, Theurl M, Gruber F, Schacherl S, Auer J, Primus C, Eber B, Ammer M, Hofer JF, Mayr H, Moser S, Hoellmueller I, Van der Werf F, Motte S, Jorion M, Schroë H, Zwinnen W, Vermassen F, Geenens M, De Wolf L, Briké C, De Deyn P, Ongena P, De Klippel N, Meeuwissen K, Desfontaines P, Tincani G, Vandermeeren Y, de Fays K, Pandolfo M, Alaerts N, Peeters A, Findik A, Tack P, deGrande E, Thijs V, Marcelis E, Van Landegem W, Vanhagendoren S, Vanhooren G, Schotte V, Celen H, Bes N, De Letter J, Holvoet G, Claerbout B, Verhamme P, Debaveye B, Bourgeois P, Debrabandere K, Stalpaert S, Dhondt E, De Maeseneire S, De Bleecker J, de Koning K, Vincent M, Tahon S, Monté C, Maes J, Vossaert R, Vandenhoven C, Roosen J, Vissers C, Sinnaeve P, de Velder L, Thoeng J, Cauwenberghs J, Deceuninck F, Nicolau J, Ardito WR, Queirantes C, de Araujo Filho JD, Queirantes CS, Ribeiro JP, Guizzardi SP, Chaves ML, Titton NF, Pereira AH, Webber I, da Silva DG Jr, Uehara RM, Brasileiro J, Maia LN, Souza A, Bodanese LC, Homem R, Friedrich MA, Macagnan AP, Dutra OP, Brum AB, Rossi PR, Herek L, Feitosa GS, Bernardes Ade S, Braga J, Rodrigues D, Guimarães A, Teixeira AB, Marin Neto JA, Tonani M, Piegas LS, Amato V, Leães P, Osorio RL, Ganem F, Vieira AP, Leao P, Kanashiro V, Franken RA, Martins EP, Gagliardi RJ, Silva L, Caffaro RA, Novaes GS, Carvalho A, Laet VL, Miranda F. Jr, Crippa BA, Saraiva JF, Ormundo CT, Speciali JG, Guandolini G, de Albuquerque DC, Silva V, Abrantes JA, Pinheiro L, Teixeira MS, Guanaes DF, Resende ES, Andrade SF, Alves ÁR Jr, Oliveira OM, Tauil CB, Araujo E, de Souza J, de Freitas GR, Horokosky AP, Barbosa EC, Muniz P, de Moraes JB Jr, Cabral M, Faria Neto JR, Belemer A, Paiva MS, Brito A, Hernandes ME, Amorim R, Pittella FJ, Brito HH, Kouz S, Roy M, Gosselin G, David M, Huynh T, Boudreault C, Heath J, Scott L, Bhargava R, Stafford C, Klinke WP, Martin L, Chan YK, Zaniol D, Rebane T, Abramovich M, Vizel S, Fox B, Kornder J, Breakwell L, Constance C, Gauthier M, Cleveland D, Valley S, Dion D, Morissette A, Vertes G, Ross B, Pandey AS, Byrne M, Abramson B, Sodhi N, Ervin F, Thiessen S, Halperin F, Stedham V, Pesant Y, Sardin V, Saw J, Tarry L, Pouliot J, Marquette S, Belisle P, Gagne D, Ducas J, Munoz A, Sussex B, Newman S, Madan M, Hsu E, Bata I, Cossett J, Glanz A, Vilag C, Paddock V, Collings E, Sabbah E, Chausse I, Fortin C, Lepage C, Chehayeb R, Viau C, Ma P, Seib M, Lamy A, Rizzo A, Rajakumar AR, Eikel L, Nigro F, Stoger S, Welsh R, Lindholm L, Parker JD, Webber S, Winkler L, Hannah G, Gupta M, Kubiak A, Mukherjee A, Bozek B, Nguyen M, Dufort L, Haichin R, Toyota V, Bujold S, Syan G, Chinnasane S, Houde G, Rousseau S, Poirier P, Lariviere M, Dupuis R, Ouimet F, Audet J, Darveau C, Labonte R, Rice T, Nawaz S, Cantor W, Robbins K, Boucher P. Jr, Roberge J, Zadra R, McPherson C, Prieto JC, Noriega V, Cereño C, Mestas M, Yovaniniz P, Ferrada W, Pincetti C, Torres G, Perez L, Villan C, Escobar E, Martin R, Padilla I, Ramirez M, Hormazabal R, Pedemonte O, Suazo E, Hasbun S, Mejias M, Cardenas F, Donoso L, Godoy I, Henriquez P, Mariné L, Vergara T, Juri C, Vergara E, Muñoz M, Solano E, Toro J, Cardenas S, Mendoza F, Martinez S, Saaibi JF, Castillo KM, Ruiz NP, Castillo T, Orozco A, Muñoz C, Martínez J, Lopez D, Ochoa J, Andrade J, Jaramillo C, Garces GP, Botero R, Cáceres A, Jaramillo M, Mejia C, Schlesinger A, Munevar V, Rodriguez J, Granados LM, Jaramillo N, Aristizabal C, Cano N, Salazar JC, Urina M, Manco T, Valenzuela C, Hernandez HJ, Delgado PS, Vagner B, Castaño LA, Ucros P, Tellez M, Delgado JA, Piedrahita CA, Crump J, Fernandez V, Quintero CA, Moreno M, Hernandez Triana E, Cuentas I, Accini JL, Accini M, Manzur F, Rivera E, Reynales H, Huertas D, Hovorka J, Filipovsky J, Hirmerova J, Peska S, Jura R, Kanovsky P, Herzig R, Jansky P, Fiala R, Kalita Z, Gatkova A, Bauer J, Fiksa J, Sedlacek J, Monhart Z, Bren J, Linhart A, Skalicka L, Vitovec J, Hlinomaz O, Parenica J, Soucek M, Rihacek I, Branny M, Sknouril L, Klimsa Z, Holub M, Línkova H, Rektor I, Mikulik R, Mayer O. Sr, Novakova B, Bar M, Brodova P, Polasek R, Sabl P, Kos P, Lorenc Z, Macel I, Graversen KH, Galatius S, Soderberg LH, Sillesen H, Madelung S, Overgård K, Stan V, Rasmussen LH, Mortensen B, Iversen HK, Back C, Olesen C, Christensen H, Pedersen A, Nielsen T, Hasain M, Tanggaard L, Husted S, Christensen LL, Haas L, Mickley H, Hosbond S, Rosenlund I, Jepsen J, Kaspersen BB, Bronnum Schou J, Hempel H, Nyvad O, Feldthaus B, Jensen BS, Jensen MK, Andersen G, Thomsen RB, Rokkedal J, Joergensen A, Bülow M, Jeppesen J, Lederballe O, Scheibel I, Sjol A, Larsen J, Graner M, Svahn T, Melin J, Kaakkomäki A, Airaksinen J, Vasankari T, Tatlisumak T, Metso M, Remes A, Näppä M, Jäkälä P, Sivenius J, Kalinen M, Roine RO, Ketola R, Bassand J, Pales D, Coisne D, Berger N, Galinier M, Rosolin N, Elbaz M, Lacassagne L, Montalescot G, Vignolles N, Gully C, Lepage I, Roynard J, Hamon M, Brucato S, Macquin Mavier I, Beitar T, Berthezene P, Medkour T, Amarenco P, Gueblaoui N, Timsit S, Riou D, Mahagne M, Suissa L, Quere I, Clouzot S, Emmerich J, Martinez I, Moulin T, Cole M, Hosseini H, Monod V, Cottin Y, Bichat F, Galley D, Beltra C, Samson Y, Pires R, Bura Riviere A, Pelvet B, Giroud M, Lecheneaut C, Ohlmann P, Ait m. bark Z, Farah B, Petit F, Caussin C, Braun C, Diehm C, Mehrhof F, Inkrot S, Darius H, Heinze H, Radke P, Kulikowsky C, Ferrari M, Utschig S, Strasser R, Haacke K, Felix SB, Bruder M, Nienaber C, Pfaff H, Sohn H, Baylacher M, Mudra H, Setzer P, Konstantinides S, Hallmann A, Kreuzer J, Tsoy I, Schneider P, Appel KF, Habermeier A, Zeiher AM, Kretschmer T, Mitrovic V, Lehinant S, Bohlscheid V, Palme B, Heuer H, Espinola Klein C, Savvidis S, Kleinertz K, Hänel J, Schmidt E, Schmidt A, Ringleb PA, Ludwig I, Dietzold M, Schaffranka A, Ranft J, Cegla C, Berrouschot J, Stoll A, Tanislav C, Brandtner MA, Rosenkranz M, Otto D, Görtler M, Barleben M, Haberl R, Miedl S, Maschke M, Schröder K, Aral Becher B, Herzog Hauff S, Guenther A, Herzau C, Hoffmann U, Roth Zetzsche S, Grond M, Becker M, Hamann G, Simon K, Köhrmann M, Glahn J, Wuttig H, Nabavi DG, Seraphin D, Schellong S, Frommhold R, Dichgans M, Doerr A, Blessing E, Buss I, Butter C, Bettin D, Grosch B, Blank E, Wong L, Liu R, Lee S, Kong S, Yu C, So E, Jakal Á, Masszi G, Czuriga I, Kapocsi J, Soós E, Csiba L, Fekete K, Valikovics A, Dioszeghy P, Muskóczki E, Csányi A, Matoltsy A, Yuval R, Bornstein N, Elimelech R, Chajek Shaul T, Bursztyn M, Hayek T, Hazbon K, Gavish D, Anat N, Wexler D, Azar P, Mosseri M, Tsirulnikov E, Rozenman Y, Logvinenko S, Tanne D, Don A, Gross B, Feldman Y, Klainman E, Genin Dmitrishin I, Eldar M, Eizenberg N, Atar S, Lasri E, Hammerman H, Aharoni G, Zimlichman R, Zuker S, Telman G, Afanasiev S, Katz A, Biton A, Goldhaber A, Goldhaber M, Elian D, Linor A, Meyuhas S, Tsalihin D, Kissos D, Lampl Y, Israelson M, Gottlieb S, Dotan L, Elis A, Karny M, Hussein O, Shestatski K, Brenner H, Segal E, Baldini U, Gavazzi A, Poloni M, Censori B, Aiazzi L, Maraglino C, Marenzi G, Specchia G, Tritto I, Golino P, CIANFLONE , DOMENICO, Martignoni A, Tamburino C, Rubartelli P, Ardissino D, Tadonio I, Stramba Badiale M, Cernuschi P, Nardulli R, Sommariva L, Giordano A, Berni A, Cavallini C, Fiscella A, Azzarelli S, Esposito G, Cassese S, Danzi G, Fattore L, Barbieri E, De Caterina R, Odero A, Puttini M, Corrada E, Monzini N, Vadalà A, Pistarini C, Scrutinio D, Ferratini M, Marcheselli S, Moretti L, Partemi L, Pupilella T, Lazzari A, Ledda A, Geraci G, Rasura M, Beccia M, Cassadonte F, Vatrano M, Bongiorni D, Mos L, Marcuzzi G, Murena E, Uguccioni L, Ferretti C, Piti ATerrosu P, Perrone PF, Marconi R, Grasso L, Severi S, Evola R, Russo N, Agnelli G, Paci C, Carugo S, Silvestri O, Testa R, Novo S., Braunwald, E, Morrow, Da, Scirica, Bm, Bonaca, Mp, Mccabe, Ch, Morin, S, Fish, P, Lamp, J, Gershman, E, Murphy, S, Deenadayalu, N, Skene, A, Hill, K, Bennett, L, Strony, J, Plat, F, Berman, G, Lipka, L, Kilian, A, He, W, Liu, X, Fox, Ka, Aylward, P, Bassand, Jp, Betriu, A, Bounameaux, H, Corbalan, R, Creager, M, Dalby, A, De Ferrari, G, Dellborg, M, Diehm, Ch, Dietz, R, Goto, S, Grande, P, Gurbel, P, Hankey, G, Isaza, D, Jensen, P, Kiss, R, Lewis, B, Merlini, P, Moliterno, D, Morais, J, Nicolau, Jc, Nieminen, M, Nilsen, D, Olin, J, Ophuis, To, Paolasso, E, Pichler, M, Shinohara, Y, Spinar, J, Teal, P, Tendera, M, Theroux, P, Thomassen, L, Van de Werf, F, White, H, Wilcox, R, Alberts, M, Ameriso, S, Diener, H, Mohr, J, Welch, M, Wiviott, Sd, Awtry, E, Berger, C, Desai, A, Gelfand, E, Ho, C, Leeman, D, Link, M, Norden, A, Pande, A, Rost, N, Ruberg, R, Silverman, S, Singhal, A, Vita, J, Frye, Rl, Bailey, Kr, Easton, J, Hochman, J, Steg, Pg, Verheught, F, Lee, K, Mauro, Do, Centurion, A, Carlevaro, O, Cardozo, E, Cartasegna, L, Soccini, N, Farras, Ha, Molina Aguirre, E, Duronto, E, Arrechavala, L, Rey, R, Stilman, A, Fernández, H, Marinsalta, G, Tartaglione, J, Chekherdemian, M, Povedano, G, Casares, E, Kantor, P, Reges, P, Cuneo, C, Martinez, G, Mackinnon, I, Bagnato, B, Fernandez, A, Funosas, C, Lozada, A, Barilati, P, Ferrari, J, Ferrari, N, Llanos, J, Casaccia, G, Giannaula, R, García Méndez, C, Cirio, J, García Dávila, C, Estol, C, Chiezzo, D, Ramirez, J, Garrido, S, López, M, Hominal, M, Bianchini, Mv, Ramos, M, Verdini, E, Herrera, G, Monne, H, Ioli, P, Samudio, Ma, Rotta Escalante, R, Tarulla, A, Reich, E, Perez, G, Milesi, R, Berli, M, Marino, J, Funes, I, Prado, A, Bezi, M, Fernandez, R, Rojas, M, Cimbaro Canella, Jp, Galarza Salazan, M, Chew, D, Horsfall, L, Claxton, A, French, J, O'Brien, K, Nelson, G, Loxton, A, Mccann, A, Downey, C, Aroney, C, Cleave, P, Worthley, S, Roach, A, Amerena, J, Long, A, Thompson, P, Ferguson, L, Fitzpatrick, M, Mackenzie, M, Youssef, G, Goldsmith, H, Jayasinghe, R, Quinlan, S, Arstall, M, Rose, J, Counsell, J, Martin, M, Crimmins, D, Slattery, A, Anderson, C, Paraskevaidis, T, Davis, S, Silver, G, Gerraty, Rp, Gapper, J, Donnan, G, Petrolo, S, Whelan, A, Tulloch, G, Singh, B, Campo, Ma, Dick, R, Savage, C, Hill, A, Conway, B, Waites, J, Keays, P, Kopp, K, Hainzer, D, Podczeck Schweighofer, A, Priesnitz, T, Drexel, H, Hagspiel, V, Foeger, B, Hilbe, C, Trinka, E, Sinadinoska, D, Pilger, E, Brodmann, M, Stöllberger, C, Jungbauer, Lv, Koppensteiner, R, Hoke, M, Grisold, W, Berger, O, Gaul, Gb, Fazekas, N, Wandaller, C, Stockenhuber, F, Rek, A, Willeit, J, Zangerle, A, Kiechl, S, Sturm, W, Theurl, M, Gruber, F, Schacherl, S, Auer, J, Primus, C, Eber, B, Ammer, M, Hofer, Jf, Mayr, H, Moser, S, Hoellmueller, I, Van der Werf, F, Motte, S, Jorion, M, Schroë, H, Zwinnen, W, Vermassen, F, Geenens, M, De Wolf, L, Briké, C, De Deyn, P, Ongena, P, De Klippel, N, Meeuwissen, K, Desfontaines, P, Tincani, G, Vandermeeren, Y, de Fays, K, Pandolfo, M, Alaerts, N, Peeters, A, Findik, A, Tack, P, Degrande, E, Thijs, V, Marcelis, E, Van Landegem, W, Vanhagendoren, S, Vanhooren, G, Schotte, V, Celen, H, Bes, N, De Letter, J, Holvoet, G, Claerbout, B, Verhamme, P, Debaveye, B, Bourgeois, P, Debrabandere, K, Stalpaert, S, Dhondt, E, De Maeseneire, S, De Bleecker, J, de Koning, K, Vincent, M, Tahon, S, Monté, C, Maes, J, Vossaert, R, Vandenhoven, C, Roosen, J, Vissers, C, Sinnaeve, P, de Velder, L, Thoeng, J, Cauwenberghs, J, Deceuninck, F, Nicolau, J, Ardito, Wr, Queirantes, C, de Araujo Filho, Jd, Ribeiro, Jp, Guizzardi, Sp, Chaves, Ml, Titton, Nf, Pereira, Ah, Webber, I, da Silva DG, Jr, Uehara, Rm, Brasileiro, J, Maia, Ln, Souza, A, Bodanese, Lc, Homem, R, Friedrich, Ma, Macagnan, Ap, Dutra, Op, Brum, Ab, Rossi, Pr, Herek, L, Feitosa, G, Bernardes Ade, S, Braga, J, Rodrigues, D, Guimarães, A, Teixeira, Ab, Marin Neto, Ja, Tonani, M, Piegas, L, Amato, V, Leães, P, Osorio, Rl, Ganem, F, Vieira, Ap, Leao, P, Kanashiro, V, Franken, Ra, Martins, Ep, Gagliardi, Rj, Silva, L, Caffaro, Ra, Novaes, G, Carvalho, A, Laet, Vl, Miranda F., Jr, Crippa, Ba, Saraiva, Jf, Ormundo, Ct, Speciali, Jg, Guandolini, G, de Albuquerque, Dc, Silva, V, Abrantes, Ja, Pinheiro, L, Teixeira, M, Guanaes, Df, Resende, E, Andrade, Sf, Alves ÁR, Jr, Oliveira, Om, Tauil, Cb, Araujo, E, de Souza, J, de Freitas, Gr, Horokosky, Ap, Barbosa, Ec, Muniz, P, de Moraes JB, Jr, Cabral, M, Faria Neto, Jr, Belemer, A, Paiva, M, Brito, A, Hernandes, Me, Amorim, R, Pittella, Fj, Brito, Hh, Kouz, S, Roy, M, Gosselin, G, David, M, Huynh, T, Boudreault, C, Heath, J, Scott, L, Bhargava, R, Stafford, C, Klinke, Wp, Martin, L, Chan, Yk, Zaniol, D, Rebane, T, Abramovich, M, Vizel, S, Fox, B, Kornder, J, Breakwell, L, Constance, C, Gauthier, M, Cleveland, D, Valley, S, Dion, D, Morissette, A, Vertes, G, Ross, B, Pandey, A, Byrne, M, Abramson, B, Sodhi, N, Ervin, F, Thiessen, S, Halperin, F, Stedham, V, Pesant, Y, Sardin, V, Saw, J, Tarry, L, Pouliot, J, Marquette, S, Belisle, P, Gagne, D, Ducas, J, Munoz, A, Sussex, B, Newman, S, Madan, M, Hsu, E, Bata, I, Cossett, J, Glanz, A, Vilag, C, Paddock, V, Collings, E, Sabbah, E, Chausse, I, Fortin, C, Lepage, C, Chehayeb, R, Viau, C, Ma, P, Seib, M, Lamy, A, Rizzo, A, Rajakumar, Ar, Eikel, L, Nigro, F, Stoger, S, Welsh, R, Lindholm, L, Parker, Jd, Webber, S, Winkler, L, Hannah, G, Gupta, M, Kubiak, A, Mukherjee, A, Bozek, B, Nguyen, M, Dufort, L, Haichin, R, Toyota, V, Bujold, S, Syan, G, Chinnasane, S, Houde, G, Rousseau, S, Poirier, P, Lariviere, M, Dupuis, R, Ouimet, F, Audet, J, Darveau, C, Labonte, R, Rice, T, Nawaz, S, Cantor, W, Robbins, K, Boucher P., Jr, Roberge, J, Zadra, R, Mcpherson, C, Prieto, Jc, Noriega, V, Cereño, C, Mestas, M, Yovaniniz, P, Ferrada, W, Pincetti, C, Torres, G, Perez, L, Villan, C, Escobar, E, Martin, R, Padilla, I, Ramirez, M, Hormazabal, R, Pedemonte, O, Suazo, E, Hasbun, S, Mejias, M, Cardenas, F, Donoso, L, Godoy, I, Henriquez, P, Mariné, L, Vergara, T, Juri, C, Vergara, E, Muñoz, M, Solano, E, Toro, J, Cardenas, S, Mendoza, F, Martinez, S, Saaibi, Jf, Castillo, Km, Ruiz, Np, Castillo, T, Orozco, A, Muñoz, C, Martínez, J, Lopez, D, Ochoa, J, Andrade, J, Jaramillo, C, Garces, Gp, Botero, R, Cáceres, A, Jaramillo, M, Mejia, C, Schlesinger, A, Munevar, V, Rodriguez, J, Granados, Lm, Jaramillo, N, Aristizabal, C, Cano, N, Salazar, Jc, Urina, M, Manco, T, Valenzuela, C, Hernandez, Hj, Delgado, P, Vagner, B, Castaño, La, Ucros, P, Tellez, M, Delgado, Ja, Piedrahita, Ca, Crump, J, Fernandez, V, Quintero, Ca, Moreno, M, Hernandez Triana, E, Cuentas, I, Accini, Jl, Accini, M, Manzur, F, Rivera, E, Reynales, H, Huertas, D, Hovorka, J, Filipovsky, J, Hirmerova, J, Peska, S, Jura, R, Kanovsky, P, Herzig, R, Jansky, P, Fiala, R, Kalita, Z, Gatkova, A, Bauer, J, Fiksa, J, Sedlacek, J, Monhart, Z, Bren, J, Linhart, A, Skalicka, L, Vitovec, J, Hlinomaz, O, Parenica, J, Soucek, M, Rihacek, I, Branny, M, Sknouril, L, Klimsa, Z, Holub, M, Línkova, H, Rektor, I, Mikulik, R, Mayer O., Sr, Novakova, B, Bar, M, Brodova, P, Polasek, R, Sabl, P, Kos, P, Lorenc, Z, Macel, I, Graversen, Kh, Galatius, S, Soderberg, Lh, Sillesen, H, Madelung, S, Overgård, K, Stan, V, Rasmussen, Lh, Mortensen, B, Iversen, Hk, Back, C, Olesen, C, Christensen, H, Pedersen, A, Nielsen, T, Hasain, M, Tanggaard, L, Husted, S, Christensen, Ll, Haas, L, Mickley, H, Hosbond, S, Rosenlund, I, Jepsen, J, Kaspersen, Bb, Bronnum Schou, J, Hempel, H, Nyvad, O, Feldthaus, B, Jensen, B, Jensen, Mk, Andersen, G, Thomsen, Rb, Rokkedal, J, Joergensen, A, Bülow, M, Jeppesen, J, Lederballe, O, Scheibel, I, Sjol, A, Larsen, J, Graner, M, Svahn, T, Melin, J, Kaakkomäki, A, Airaksinen, J, Vasankari, T, Tatlisumak, T, Metso, M, Remes, A, Näppä, M, Jäkälä, P, Sivenius, J, Kalinen, M, Roine, Ro, Ketola, R, Bassand, J, Pales, D, Coisne, D, Berger, N, Galinier, M, Rosolin, N, Elbaz, M, Lacassagne, L, Montalescot, G, Vignolles, N, Gully, C, Lepage, I, Roynard, J, Hamon, M, Brucato, S, Macquin Mavier, I, Beitar, T, Berthezene, P, Medkour, T, Amarenco, P, Gueblaoui, N, Timsit, S, Riou, D, Mahagne, M, Suissa, L, Quere, I, Clouzot, S, Emmerich, J, Martinez, I, Moulin, T, Cole, M, Hosseini, H, Monod, V, Cottin, Y, Bichat, F, Galley, D, Beltra, C, Samson, Y, Pires, R, Bura Riviere, A, Pelvet, B, Giroud, M, Lecheneaut, C, Ohlmann, P, Ait m., bark Z, Farah, B, Petit, F, Caussin, C, Braun, C, Diehm, C, Mehrhof, F, Inkrot, S, Darius, H, Heinze, H, Radke, P, Kulikowsky, C, Ferrari, M, Utschig, S, Strasser, R, Haacke, K, Felix, Sb, Bruder, M, Nienaber, C, Pfaff, H, Sohn, H, Baylacher, M, Mudra, H, Setzer, P, Konstantinides, S, Hallmann, A, Kreuzer, J, Tsoy, I, Schneider, P, Appel, Kf, Habermeier, A, Zeiher, Am, Kretschmer, T, Mitrovic, V, Lehinant, S, Bohlscheid, V, Palme, B, Heuer, H, Espinola Klein, C, Savvidis, S, Kleinertz, K, Hänel, J, Schmidt, E, Schmidt, A, Ringleb, Pa, Ludwig, I, Dietzold, M, Schaffranka, A, Ranft, J, Cegla, C, Berrouschot, J, Stoll, A, Tanislav, C, Brandtner, Ma, Rosenkranz, M, Otto, D, Görtler, M, Barleben, M, Haberl, R, Miedl, S, Maschke, M, Schröder, K, Aral Becher, B, Herzog Hauff, S, Guenther, A, Herzau, C, Hoffmann, U, Roth Zetzsche, S, Grond, M, Becker, M, Hamann, G, Simon, K, Köhrmann, M, Glahn, J, Wuttig, H, Nabavi, Dg, Seraphin, D, Schellong, S, Frommhold, R, Dichgans, M, Doerr, A, Blessing, E, Buss, I, Butter, C, Bettin, D, Grosch, B, Blank, E, Wong, L, Liu, R, Lee, S, Kong, S, Yu, C, So, E, Jakal, Á, Masszi, G, Czuriga, I, Kapocsi, J, Soós, E, Csiba, L, Fekete, K, Valikovics, A, Dioszeghy, P, Muskóczki, E, Csányi, A, Matoltsy, A, Yuval, R, Bornstein, N, Elimelech, R, Chajek Shaul, T, Bursztyn, M, Hayek, T, Hazbon, K, Gavish, D, Anat, N, Wexler, D, Azar, P, Mosseri, M, Tsirulnikov, E, Rozenman, Y, Logvinenko, S, Tanne, D, Don, A, Gross, B, Feldman, Y, Klainman, E, Genin Dmitrishin, I, Eldar, M, Eizenberg, N, Atar, S, Lasri, E, Hammerman, H, Aharoni, G, Zimlichman, R, Zuker, S, Telman, G, Afanasiev, S, Katz, A, Biton, A, Goldhaber, A, Goldhaber, M, Elian, D, Linor, A, Meyuhas, S, Tsalihin, D, Kissos, D, Lampl, Y, Israelson, M, Gottlieb, S, Dotan, L, Elis, A, Karny, M, Hussein, O, Shestatski, K, Brenner, H, Segal, E, Baldini, U, Gavazzi, A, Poloni, M, Censori, B, Aiazzi, L, Maraglino, C, Marenzi, G, Specchia, G, Tritto, I, Golino, P, Cianflone, Domenico, Martignoni, A, Tamburino, C, Rubartelli, P, Ardissino, D, Tadonio, I, Stramba Badiale, M, Cernuschi, P, Nardulli, R, Sommariva, L, Giordano, A, Berni, A, Cavallini, C, Fiscella, A, Azzarelli, S, Esposito, G, Cassese, S, Danzi, G, Fattore, L, Barbieri, E, De Caterina, R, Odero, A, Puttini, M, Corrada, E, Monzini, N, Vadalà, A, Pistarini, C, Scrutinio, D, Ferratini, M, Marcheselli, S, Moretti, L, Partemi, L, Pupilella, T, Lazzari, A, Ledda, A, Geraci, G, Rasura, M, Beccia, M, Cassadonte, F, Vatrano, M, Bongiorni, D, Mos, L, Marcuzzi, G, Murena, E, Uguccioni, L, Ferretti, C, Piti ATerrosu, P, Perrone, Pf, Marconi, R, Grasso, L, Severi, S, Evola, R, Russo, N, Agnelli, G, Paci, C, Carugo, S, Silvestri, O, Testa, R, and Novo, S.
- Abstract
BACKGROUND:Thrombin potently activates platelets through the protease-activated receptor PAR-1. Vorapaxar is a novel antiplatelet agent that selectively inhibits the cellular actions of thrombin through antagonism of PAR-1.METHODS:We randomly assigned 26,449 patients who had a history of myocardial infarction, ischemic stroke, or peripheral arterial disease to receive vorapaxar (2.5 mg daily) or matching placebo and followed them for a median of 30 months. The primary efficacy end point was the composite of death from cardiovascular causes, myocardial infarction, or stroke. After 2 years, the data and safety monitoring board recommended discontinuation of the study treatment in patients with a history of stroke owing to the risk of intracranial hemorrhage.RESULTS:At 3 years, the primary end point had occurred in 1028 patients (9.3%) in the vorapaxar group and in 1176 patients (10.5%) in the placebo group (hazard ratio for the vorapaxar group, 0.87; 95% confidence interval [CI], 0.80 to 0.94; P
- Published
- 2012
12. P160 - CANCER DISEASE IN THE EMERGENCY DEPARTMENT AND ITS IMPACT ON HOSPITALIZATION AND LENGTH OF STAY
- Author
-
Gil Jr, L.A., Curiati, P.K., Curiati, J.A., Morinaga, C.V., Ganem, F., Cabral, K.N., Olivieri, F.C., Sasdelli, R., Braga, J.L., Correa, F.G., Margarido, B.C., and Silva, T.J.Avelino
- Published
- 2019
- Full Text
- View/download PDF
13. [PP.27.07] SUCCESSIVE BLOOD PRESSURE MEASUREMENT LOSES ACCURACY IN BORDERLINE VALUES OF BLOOD PRESSURE
- Author
-
Silva, M. Vieira Da, primary, Silva, A. Mendes Da, additional, Giorgi, D. Artigas, additional, Ganem, F., additional, and Resende, L.P. Rodriges De, additional
- Published
- 2016
- Full Text
- View/download PDF
14. [PP.27.22] WHAT IS THE OPTIMAL NUMBERS OF SEQUENTIAL MEASUREMENTS TO IMPROVE THE ACCURACY OF OFFICE BLOOD PRESSURE?
- Author
-
Silva, M. Vieira Da, primary, Silva, A. Mendes Da, additional, Giorgi, D. Artigas, additional, Ganem, F., additional, Resende, L.P. Rodriges De, additional, and Resende, E.M. Rodrigues De, additional
- Published
- 2016
- Full Text
- View/download PDF
15. PP.03.06
- Author
-
Da Silva, M. Vieira, primary, Da Silva, A. Mendes, additional, Giorgi, D. Artigas, additional, Ganem, F., additional, and De Resende, L. Rodrigues, additional
- Published
- 2015
- Full Text
- View/download PDF
16. Meningioma of the third ventricle.
- Author
-
Sayette, V., Rivaton, F., Chapon, F., Hubert, P., Ganem, F., and Houtteville, J.
- Abstract
Meningiomas of the third ventricle are rare intracranial neoplasms. We reported such a case in a 42 years old man without clinical evidence of increased intracranial pressure. Computed tomography (CT) and magnetic resonance imaging (MRI) demonstrated the tumour sitting in the superior and anterior part of the third ventricle, bulging into the lateral ventricles. CT was more effective than MRI in the demonstration of calcifications whereas MRI proved to be superior in delineation of the tumour and its relation with surrounding structures. [ABSTRACT FROM AUTHOR]
- Published
- 1991
- Full Text
- View/download PDF
17. [Brazilian guidelines on platelet antiaggregants and anticoagulants in cardiology].,Diretrizes brasileiras de antiagregantes plaquetários e anticoagulantes em cardiologia
- Author
-
Sociedade Brasileira de Cardiologia, Lorga Filho, A. M., Azmus, A. D., Soeiro, A. M., Quadros, A. S., Avezum Jr, A., Marques, A. C., Franci, A., Manica, A. L., Volschan, A., Paola, A. A., Greco, A. I., Ferreira, A. C., Sousa, A. C., Pesaro, A. E., Simão, A. F., Lopes, A. S., Timerman, A., Ramos, A. I., Alves, B. R., Caramelli, B., Mendes, B. A., Polanczyk, C. A., Montenegro, C. E., Barbosa, C. J., Serrano Jr, C. V., Melo, C. C., Pinho, C., Moreira, D. A., Calderaro, D., Gualandro, D. M., Armaganijan, D., Machado Neto, E. A., Bocchi, E. A., Paiva, E. F., Stefanini, E., D Amico, E., Evaristo, E. F., Silva, E. E., Fernandes, F., Brito Jr, F. S., Bacal, F., Ganem, F., Gomes, F. L., Mattos, F. R., Moraes Neto, F. R., Tarasoutchi, F., FRANCISCO DARRIEUX, Feitosa, G. S., Fenelon, G., Morais, G. R., Correa Filho, H., Castro, I., Gonçalves Jr, I., Atié, J., Souza Neto, J. D., Ferreira, J. F., Nicolau, J. C., Faria Neto, J. R., Annichino-Bizzacchi, J. M., Zimerman, L. I., Piegas, L. S., Pires, L. J., Baracioli, L. M., Silva, L. B., Mattos, L. A., Lisboa, L. A., Magalhães, L. P., Lopes, M. A., Montera, M. W., Figueiredo, M. J., Malachias, M. V., Gaz, M. V., Andrade, M. D., Bacellar, M. S., Barbosa, M. R., Clausell, N. O., Dutra, O. P., Coelho, O. R., Yu, P. C., Lavítola, P. L., Lemos Neto, P. A., Andrade, P. B., Farsky, P. S., Franco, R. A., Kalil, R. A., Lopes, R. D., Esporcatte, R., Heinisch, R. H., Kalil Filho, R., Giraldez, R. R., Alves, R. C., Leite, R. E., Gagliardi, R. J., Ramos, R. F., Montenegro, S. T., Accorsi, T. A., Jardim, T. S., and Scudeler, T. L.
18. [Brazilian guidelines on platelet antiaggregants and anticoagulants in cardiology]. | Diretrizes brasileiras de antiagregantes plaquetários e anticoagulantes em cardiologia
- Author
-
Sociedade Brasileira de Cardiologia, Lorga Filho, A. M., Azmus, A. D., Soeiro, A. M., Quadros, A. S., Avezum Jr, A., Marques, A. C., Franci, A., Manica, A. L., Volschan, A., Paola, A. A., Greco, A. I., Ferreira, A. C., Sousa, A. C., Pesaro, A. E., Simão, A. F., Lopes, A. S., Timerman, A., Ramos, A. I., Alves, B. R., Caramelli, B., Mendes, B. A., Polanczyk, C. A., Montenegro, C. E., Barbosa, C. J., Serrano Jr, C. V., Melo, C. C., Pinho, C., Moreira, D. A., Calderaro, D., Gualandro, D. M., Armaganijan, D., Machado Neto, E. A., Bocchi, E. A., Paiva, E. F., Stefanini, E., D Amico, E., Evaristo, E. F., Silva, E. E., Fernandes, F., Brito Jr, F. S., Bacal, F., Ganem, F., Gomes, F. L., Mattos, F. R., Moraes Neto, F. R., Tarasoutchi, F., Darrieux, F. C., Feitosa, G. S., Fenelon, G., Morais, G. R., Correa Filho, H., Castro, I., Gonçalves Jr, I., Atié, J., Souza Neto, J. D., Ferreira, J. F., Nicolau, J. C., Faria Neto, J. R., Annichino-Bizzacchi, J. M., Zimerman, L. I., Leopoldo Piegas, Pires, L. J., Baracioli, L. M., Silva, L. B., Mattos, L. A., Lisboa, L. A., Magalhães, L. P., Lopes, M. A., Montera, M. W., Figueiredo, M. J., Malachias, M. V., Gaz, M. V., Andrade, M. D., Bacellar, M. S., Barbosa, M. R., Clausell, N. O., Dutra, O. P., Coelho, O. R., Yu, P. C., Lavítola, P. L., Lemos Neto, P. A., Andrade, P. B., Farsky, P. S., Franco, R. A., Kalil, R. A., Lopes, R. D., Esporcatte, R., Heinisch, R. H., Kalil Filho, R., Giraldez, R. R., Alves, R. C., Leite, R. E., Gagliardi, R. J., Ramos, R. F., Montenegro, S. T., Accorsi, T. A., Jardim, T. S., and Scudeler, T. L.
19. PP.03.06
- Author
-
Silva, M. Vieira Da, Silva, A. Mendes Da, Giorgi, D. Artigas, Ganem, F., and Resende, L. Rodrigues De
- Abstract
To evaluate the prevalence four BP profiles, Hypertension, Normal, White Coat (WCH), Masked Hypertension (MH), using three configurations of office measurement blood pressure (BP).
- Published
- 2015
- Full Text
- View/download PDF
20. Determinants of COVID-19 vaccine hesitancy among students and parents in Sentinel Schools Network of Catalonia, Spain
- Author
-
Ganem dos Santos, Fabiana Sherine, Folch, Cinta, Colom Cadena, Andreu, Bordas, Anna, Alonso García, Lucia, Soriano Arandes, Antoni, Casabona, Jordi, Institut Català de la Salut, [Ganem F] Centre d’Estudis Epidemiològics Sobre les ITS i Sida de Catalunya (CEEISCAT), Badalona, Spain. Departament de Pediatria, d’Obstetrícia i Ginecologia i de Medicina Preventiva i de Salut Publica, Universitat Autònoma de Barcelona, Bellaterra, Spain. Institut d’Investigació Germans Trias i Pujol (IGTP), Badalona, Spain. [Folch C] Centre d’Estudis Epidemiològics Sobre les ITS i Sida de Catalunya (CEEISCAT), Badalona, Spain. Institut d’Investigació Germans Trias i Pujol (IGTP), Badalona, Spain. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. [Colom-Cadena A, Bordas A] Centre d’Estudis Epidemiològics Sobre les ITS i Sida de Catalunya (CEEISCAT), Badalona, Spain. Institut d’Investigació Germans Trias i Pujol (IGTP), Badalona, Spain. [Alonso L] Institut d’Investigació Germans Trias i Pujol (IGTP), Badalona, Spain. Fundació Lluita Contra les Infeccions, Badalona, Spain. [Soriano-Arandes A] Unitat de Patologia Infecciosa i Immunodeficiències de Pediatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Casabona J] Centre d’Estudis Epidemiològics Sobre les ITS i Sida de Catalunya (CEEISCAT), Badalona, Spain. Departament de Pediatria, d’Obstetrícia i Ginecologia i de Medicina Preventiva i de Salut Publica, Universitat Autònoma de Barcelona, Bellaterra, Spain. Institut d’Investigació Germans Trias i Pujol (IGTP), Badalona, Spain. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
Multidisciplinary ,Pares ,Persons::Parents [NAMED GROUPS] ,Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunotherapy, Active::Vaccination [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT] ,virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES] ,Persons::Students [NAMED GROUPS] ,Estudiants ,Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES] ,personas::padres [DENOMINACIONES DE GRUPOS] ,COVID-19 (Malaltia) - Vacunació ,terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunoterapia activa::vacunación [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS] ,personas::estudiantes [DENOMINACIONES DE GRUPOS] - Abstract
Vacunas; COVID-19; Escuelas Vaccines; COVID-19; Schools Vacunes; COVID-19; Escoles Vaccine hesitancy is defined as a delay in acceptance of vaccines despite its availability, caused by many determinants. Our study presents the key reasons, determinants and characteristics associated with COVID-19 vaccine acceptability among students over 16 years and parents of students under 16 years and describe the COVID-19 vaccination among students in the settings of sentinel schools of Catalonia, Spain. This is a cross-sectional study that includes 3,383 students and the parents between October 2021 and January 2022. We describe the student’s vaccination status and proceed a univariate and multivariate analysis using a Deletion Substitution Addition (DSA) machine learning algorithm. Vaccination against COVID-19 reached 70.8% in students under 16 years and 95.8% in students over 16 years at the end of the study project. The acceptability among unvaccinated students was 40.9% and 20.8% in October and January, respectively, and among parents was proportionally higher among students aged 5–11 (70.2%) in October and aged 3–4 (47.8%) in January. The key reason to not vaccinate themselves, or their children, were concern about side effects, insufficient research about the effect of the vaccine in children, rapid development of vaccines, necessity for more information and previous infection by SARS-CoV-2. Several variables were associated with refusal end hesitancy. For students, the main ones were risk perception and use of alternative therapies. For parents, the age of students, sociodemographic variables, socioeconomic impact related to the pandemic, and use of alternative therapies were more evident. Monitoring vaccine acceptance and refusal among children and their parents has been important to understand the interaction between different multilevel determinants and we hope it will be useful to improve public health strategies for future interventions in this population. This work was supported by the Health Department of the Government of Catalonia with no grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FG, AB, LA and AC received a salary from the abovementioned funder.
- Published
- 2023
21. The COVID-19 Sentinel Schools Network of Catalonia (CSSNC) project: Associated factors to prevalence and incidence of SARS-CoV-2 infection in educational settings during the 2020–2021 academic year
- Author
-
Fabiana, Ganem, Anna, Bordas, Cinta, Folch, Lucia, Alonso, Marcos, Montoro-Fernandez, Andreu, Colom-Cadena, Ariadna, Mas, Jacobo, Mendioroz, Laia, Asso, Andres, Anton, Tomàs, Pumarola, Maria Victoria, González, Ignacio, Blanco, Pere, Soler-Palacín, Antoni, Soriano-Arandes, Jordi, Casabona, Institut Català de la Salut, [Ganem F] Centre of Epidemiological Studies on Sexually Transmitted Infections and AIDS of Catalonia (CEEISCAT), Health Department, Government of Catalonia, Badalona, Spain. Departament de Pediatria, d’Obstetrícia i Ginecologia i de Medicina Preventiva i de Salut Publica, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Bordas A, Alonso L, Colom-Cadena A] Centre of Epidemiological Studies on Sexually Transmitted Infections and AIDS of Catalonia (CEEISCAT), Health Department, Government of Catalonia, Badalona, Spain. Institut d’Investigació Germans Trias i Pujol (IGTP), Badalona, Spain. [Folch C] Centre of Epidemiological Studies on Sexually Transmitted Infections and AIDS of Catalonia (CEEISCAT), Health Department, Government of Catalonia, Badalona, Spain. Institut d’Investigació Germans Trias i Pujol (IGTP), Badalona, Spain. Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. [Montoro-Fernandez M] Centre of Epidemiological Studies on Sexually Transmitted Infections and AIDS of Catalonia (CEEISCAT), Health Department, Government of Catalonia, Badalona, Spain. [Anton A, Pumarola T] Servei de Microbiologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellatera, Spain. [Soler-Palacín P, Soriano-Arandes A] Unitat de Patologia Infecciosa i Immunodeficiències de Pediatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
vigilancia sanitaria de los servicios de salud::centros sanitarios::instituciones residenciales::escuelas [VIGILANCIA SANITARIA] ,Schools ,Multidisciplinary ,SARS-CoV-2 ,Other subheadings::Other subheadings::/epidemiology [Other subheadings] ,Incidence ,COVID-19 (Malaltia) - Epidemiologia ,COVID-19 (Malaltia) - Factors de risc ,Otros calificadores::Otros calificadores::/epidemiología [Otros calificadores] ,técnicas de investigación::métodos epidemiológicos::recopilación de datos::estadísticas vitales::morbilidad::prevalencia [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS] ,COVID-19 ,Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES] ,Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Prevalence [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT] ,Health Surveillance of Health Services::Health Facilities::Residential Facilities::Schools [HEALTH SURVEILLANCE] ,Cross-Sectional Studies ,Escoles ,Seroepidemiologic Studies ,Spain ,virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES] ,Prevalence ,Humans ,Child - Abstract
COVID-19; Medical risk factors; Virus testing COVID-19; Factors de risc mèdics; Test de virus COVID-19; Factores de riesgo médicos; Test de virus The Sentinel Schools project was designed to monitor and evaluate the epidemiology of COVID-19 in Catalonia, gathering evidence for health and education policies to inform the development of health protocols and public health interventions to control of SARS-CoV-2 infection in schools. The aim of this study was to estimate the prevalence and incidence of SARS-CoV-2 infections and to identify their determinants among students and staff during February to June in the academic year 2020–2021. We performed two complementary studies, a cross-sectional and a longitudinal component, using a questionnaire to collect nominal data and testing for SARS-CoV-2 detection. We describe the results and perform a univariate and multivariate analysis. The initial crude seroprevalence was 14.8% (95% CI: 13.1–16.5) and 22% (95% CI: 18.3–25.8) for students and staff respectively, and the active infection prevalence was 0.7% (95% CI: 0.3–1) and 1.1% (95% CI: 0.1–2). The overall incidence for persons at risk was 2.73 per 100 person-month and 2.89 and 2.34 per 100 person-month for students and staff, respectively. Socioeconomic, self-reported knowledge, risk perceptions and contact pattern variables were positively associated with the outcome while sanitary measure compliance was negatively associated, the same significance trend was observed in multivariate analysis. In the longitudinal component, epidemiological close contact with SARS-CoV-2 infection was a risk factor for SARS-CoV-2 infection while the highest socioeconomic status level was protective as was compliance with sanitary measures. The small number of active cases detected in these schools suggests a low transmission among children in school and the efficacy of public health measures implemented, at least in the epidemiological scenario of the study period. The major contribution of this study was to provide results and evidence that help analyze the transmission dynamic of SARS-CoV-2 and evaluate the associations between sanitary protocols implemented, and measures to avoid SARS-CoV-2 spread in schools.
- Published
- 2022
- Full Text
- View/download PDF
22. Determinants of school absences due to respiratory tract infections among children during COVID-19 pandemic: A cross-sectional study of the Sentinel Schools Network.
- Author
-
Soriano-Arandes A, Colom-Cadena A, Bordas A, Ganem F, Alonso L, Montoro M, Gascon M, Subirana M, Mas A, Sunyer J, Soler-Palacin P, and Casabona J
- Subjects
- Child, Humans, Cross-Sectional Studies, Pandemics, Environmental Monitoring, Schools, COVID-19 epidemiology, Respiratory Tract Infections epidemiology, Air Pollution, Indoor, Air Pollutants analysis
- Published
- 2024
- Full Text
- View/download PDF
23. Impact of the COVID-19 pandemic on the psychological well-being of adolescents by gender identity.
- Author
-
Folch C, Ganem F, Colom-Cadena A, Martínez I, Cabezas C, and Casabona J
- Subjects
- Humans, Adolescent, Female, Male, Gender Identity, Pandemics, Cross-Sectional Studies, Psychological Well-Being, COVID-19 epidemiology
- Abstract
Objective: To describe the impact of the COVID-19 pandemic on the psychological well-being of adolescents in Catalan schools by gender identity, and to compare coping strategies adopted to manage the health crisis and their relationship with the self-perceived impact of COVID-19 on mental health., Method: Cross-sectional study in educational centres that includes 1171 adolescents over 15 years old from October to November 2021. Multivariate logistic regression models were built to evaluate the association between coping strategies with self-perceived impact of the pandemic on mental health., Results: A greater proportion of girls perceived a worsening in mental health than boys due to COVID-19 (36.9% and 17.8%, respectively). The main emotions reported for both girls and boys were worry and boredom. The study found an association between positive coping strategies with less adverse mental health among girls, whereas unhealthy habits were associated with a higher probability of declaring worsening of mental health for both girls and boys., Conclusions: This study demonstrated the negative impact of the COVID-19 pandemic on psychological well-being in adolescents and a clearly worse impact on girls. It is important to keep monitoring the medium- and long-term secondary impacts of the pandemic on mental health outcomes of adolescents and to gather information that can improve services for the development of healthy coping strategies during health crises like COVID-19, which include gender perspective., (Copyright © 2023 SESPAS. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
24. Determinants of COVID-19 vaccine hesitancy among students and parents in Sentinel Schools Network of Catalonia, Spain.
- Author
-
Ganem F, Folch C, Colom-Cadena A, Bordas A, Alonso L, Soriano-Arandes A, and Casabona J
- Subjects
- Child, Humans, Spain epidemiology, Cross-Sectional Studies, SARS-CoV-2, Parents, Schools, Students, Vaccination, COVID-19 Vaccines, COVID-19 epidemiology, COVID-19 prevention & control
- Abstract
Vaccine hesitancy is defined as a delay in acceptance of vaccines despite its availability, caused by many determinants. Our study presents the key reasons, determinants and characteristics associated with COVID-19 vaccine acceptability among students over 16 years and parents of students under 16 years and describe the COVID-19 vaccination among students in the settings of sentinel schools of Catalonia, Spain. This is a cross-sectional study that includes 3,383 students and the parents between October 2021 and January 2022. We describe the student's vaccination status and proceed a univariate and multivariate analysis using a Deletion Substitution Addition (DSA) machine learning algorithm. Vaccination against COVID-19 reached 70.8% in students under 16 years and 95.8% in students over 16 years at the end of the study project. The acceptability among unvaccinated students was 40.9% and 20.8% in October and January, respectively, and among parents was proportionally higher among students aged 5-11 (70.2%) in October and aged 3-4 (47.8%) in January. The key reason to not vaccinate themselves, or their children, were concern about side effects, insufficient research about the effect of the vaccine in children, rapid development of vaccines, necessity for more information and previous infection by SARS-CoV-2. Several variables were associated with refusal end hesitancy. For students, the main ones were risk perception and use of alternative therapies. For parents, the age of students, sociodemographic variables, socioeconomic impact related to the pandemic, and use of alternative therapies were more evident. Monitoring vaccine acceptance and refusal among children and their parents has been important to understand the interaction between different multilevel determinants and we hope it will be useful to improve public health strategies for future interventions in this population., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2023 Ganem et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
25. The first year of the COVID-19 pandemic in an indigenous population in Brazil: an epidemiological study.
- Author
-
Croda MG, Barbosa MDS, Marchioro SB, Nascimento DDGD, Melo ECP, Cruz OG, Torres AJL, Oliveira LA, Ganem F, and Simionatto S
- Subjects
- Humans, Female, Young Adult, Adult, Middle Aged, Male, Pandemics, Indigenous Peoples, Indians, South American, Cross-Sectional Studies, Brazil epidemiology, COVID-19 epidemiology
- Abstract
This cross-sectional observational study that describes the epidemiological data of the first year of the COVID-19 pandemic in the Mato Grosso do Sul State, aimed to demonstrate the differences between indigenous and non-indigenous populations, characterize confirmed cases of COVID-19 according to risk factors related to ethnicity, comorbidities and their evolution and to verify the challenges in facing the disease in Brazil. SIVEP-Gripe and E-SUS-VE, a nationwide surveillance database in Brazil, from March 2020 to March 2021 in Mato Grosso do Sul state, were used to compare survivors and non-survivors from indigenous and non-indigenous populations and the epidemiological incidence curves of these populations. A total of 176,478, including 5,299 indigenous people, were confirmed. Among the indigenous population, 52.5% (confidence interval [CI] 51.2-53.9) were women, 38% (CI 36.7-39.4) were 20-39 years old, 56.7% were diagnosed by rapid antibody tests, 12.3% (CI 95%:11.5-13.2) had at least one comorbidity, and 5.3% (CI 95%:4.7-5.9) were hospitalized. In the non-indigenous patients, 56.8% were confirmed using RT-PCR, 4.4% (CI 95%:4.3-4.5) had at least one comorbidity, and 8.0% (CI 95%:7.9-8.2) were hospitalized. The majority of non-survivors were ≥60 years old (65.1% indigenous vs. 74.1% non-indigenous). The mortality in indigenous people was more than three times higher (11% vs. 2.9%). Indigenous people had a lower proportion of RT-PCR diagnoses; deaths were more frequent in younger patients and were less likely to be admitted to hospital. Mass vaccination may have controlled the incidence and mortality associated with COVID-19 in this population during the period of increased viral circulation.
- Published
- 2022
- Full Text
- View/download PDF
26. Seroprevalence of SARS-CoV-2 in Emergency Department Healthcare Workers at Sírio-Libanês Hospital, Brazil.
- Author
-
Madureira R, Ferreira SA, Marion MAL, Bettoni F, Ganem F, Camargo AA, and Morinaga CV
- Subjects
- Humans, Seroepidemiologic Studies, Brazil epidemiology, Health Personnel, Hospitals, Emergency Service, Hospital, Immunoglobulin G, Antibodies, Neutralizing, SARS-CoV-2, COVID-19 epidemiology
- Abstract
COVID-19 has spread rapidly worldwide. Information on its prevalence and factors associated with infection are important for protecting both professionals and patients in healthcare centers. This study evaluated the seroprevalence of antibodies against SARS-CoV-2 and its association with the degree of exposure and use of personal protective equipment by healthcare professionals dedicated to the treatment of patients with flu-like illnesses in the emergency room. The research team included an analysis of healthcare professionals who underwent enzyme-linked immunosorbent assay serological testing for SARS-CoV-2 between May 28 and June 26, 2020, in the emergency room of Sírio-Libanês Hospital in São Paulo, Brazil. Participants answered individual questionnaires on occupational information, medical health history, and factors associated with exposure to the novel coronavirus. The questionnaire variables were compared based on the serological results. Of the 164 study participants, 96 (58.54%) reported at least 1 flu-like symptom and 42 (25.61%) presented serology results that were compatible with SARS-CoV-2 infection. The asymptomatic declared group accounted for 62 participants; of these, 8 (12.90%) had positive serology results (neutralizing antibody and IgG) for SARS-CoV-2. Data analysis showed a positive correlation with duration of work, safety in wearing and reusing personal protective equipment, and presence of anosmia, and showed a negative relationship with duration of mask use. Our findings suggest that the perception of symptoms by healthcare professionals is not a good screening parameter for the diagnosis of an infectious disease with respiratory symptoms, such as COVID-19. The main influencing factor for the control of infection is the elaboration of workflows and safety protocols based on simple and clear rules as well as investments in team training.
- Published
- 2022
- Full Text
- View/download PDF
27. Ganglionar tuberculosis infection evolving to hemophagocytic lymphohistiocytosis after anti-programmed cell death 1 treatment for high-risk melanoma: a case report.
- Author
-
Costa CM, Gadotti LL, Seiwald MC, Salgues ACR, Ganem F, Nascimento ECT, Uip DE, Arrais-Rodrigues C, and Munhoz RR
- Subjects
- Aged, Humans, Male, Nivolumab, Lymphohistiocytosis, Hemophagocytic drug therapy, Melanoma drug therapy, Sarcoidosis, Tuberculosis
- Abstract
Background: Hemophagocytic lymphohistiocytosis is a rare, potentially fatal syndrome of immune hyperactivation. Here we describe a ganglionar tuberculosis evolving to hemophagocytic lymphohistiocytosis following adjuvant immunotherapy in a melanoma patient., Case Presentation: A 76-year-old Caucasian male with melanoma started with fever, diffuse petechiae, splenomegaly, anemia, thrombocytopenia, hypofibrinogenemia, and hyperferritinemia 2 months following completion of adjuvant treatment with nivolumab. Positron emission tomography scan showed significant hypermetabolism in cervical, supraclavicular, mediastinal, and abdominal lymph nodes. Bone marrow aspiration demonstrated no alterations, except for a hypercellular pattern. Dexamethasone and intravenous immunoglobulin were started owing to suspicion of hemophagocytic lymphohistiocytosis. Core biopsy of the infracarinal lymph node revealed a chronic granulomatous inflammation and caseous necrosis, with positivity for Mycobacterium tuberculosis by polymerase chain reaction, and treatment for ganglionar tuberculosis was started., Conclusion: This case highlights the challenges involving programmed cell death 1 blockade in high-risk melanoma, in which infections, lymphoproliferative disorders, and sarcoidosis can mimic disease progression and trigger immune-related adverse events.
- Published
- 2021
- Full Text
- View/download PDF
28. Resuscitation fluid practices in Brazilian intensive care units: a secondary analysis of Fluid-TRIPS.
- Author
-
Freitas FGR, Hammond N, Li Y, Azevedo LCP, Cavalcanti AB, Taniguchi L, Gobatto A, Japiassú AM, Bafi AT, Mazza BF, Noritomi DT, Dal-Pizzol F, Bozza F, Salluh JIF, Westphal GA, Soares M, Assunção MSC, Lisboa T, Lobo SMA, Barbosa AR, Ventura AF, Souza AF, Silva AF, Toledo A, Reis A, Cembranel A, Rea Neto A, Gut AL, Justo APP, Santos AP, Albuquerque ACD, Scazufka A, Rodrigues AB, Fernandino BB, Silva BG, Vidal BS, Pinheiro BV, Pinto BVC, Feijo CAR, Abreu Filho C, Bosso CEDCN, Moreira CEN, Ramos CHF, Tavares C, Arantes C, Grion C, Mendes CL, Kmohan C, Piras C, Castro CPP, Lins C, Beraldo D, Fontes D, Boni D, Castiglioni D, Paisani DM, Pedroso DFF, Mattos ER, Brito Sobrinho E, Troncoso EMV, Rodrigues Filho EM, Nogueira EEF, Ferreira EL, Pacheco ES, Jodar E, Ferreira ELA, Araujo FF, Trevisol FS, Amorim FF, Giannini FP, Santos FPM, Buarque F, Lima FG, Costa FAAD, Sad FCDA, Aranha FG, Ganem F, Callil F, Costa Filho FF, Dall Arto FTC, Moreno G, Friedman G, Moralez GM, Silva GAD, Costa G, Cavalcanti GS, Cavalcanti GS, Betônico GN, Betônico GN, Reis H, Araujo HBN, Hortiz Júnior HA, Guimaraes HP, Urbano H, Maia I, Santiago Filho IL, Farhat Júnior J, Alvarez JR, Passos JT, Paranhos JEDR, Marques JA, Moreira Filho JG, Andrade JN, Sobrinho JOC, Bezerra JTP, Alves JA, Ferreira J, Gomes J, Sato KM, Gerent K, Teixeira KMC, Conde KAP, Martins LF, Figueirêdo L, Rezegue L, Tcherniacovsk L, Ferraz LO, Cavalcante L, Rabelo L, Miilher L, Garcia L, Tannous L, Hajjar LA, Paciência LEM, Cruz Neto LMD, Bley MV, Sousa MF, Puga ML, Romano MLP, Nobrega M, Arbex M, Rodrigues ML, Guerreiro MO, Rocha M, Alves MAP, Alves MAP, Rosa MD, Dias MD, Martins M, Oliveira M, Moretti MMS, Matsui M, Messender O, Santarém OLA, Silveira PJHD, Vassallo PF, Antoniazzi P, Gottardo PC, Correia P, Ferreira P, Torres P, Silva PGMBE, Foernges R, Gomes R, Moraes R, Nonato Filho R, Borba RL, Gomes RV, Cordioli R, Lima R, López RP, Gargioni RRO, Rosenblat R, Souza RM, Almeida R, Narciso RC, Marco R, Waltrick R, Biondi R, Figueiredo R, Dutra RS, Batista R, Felipe R, Franco RSDS, Houly S, Faria SS, Pinto SF, Luzzi S, Sant'ana S, Fernandes SS, Yamada S, Zajac S, Vaz SM, Bezerra SAB, Farhat TBT, Santos TM, Smith T, Silva UVA, Damasceno VB, Nobre V, Dantas VCS, Irineu VM, Bogado V, Nedel W, Campos Filho W, Dantas W, Viana W, Oliveira Filho W, Delgadinho WM, Finfer S, and Machado FR
- Subjects
- Brazil, Cross-Sectional Studies, Fluid Therapy, Humans, Intensive Care Units, Isotonic Solutions, Prospective Studies, Resuscitation, Critical Illness, Rehydration Solutions
- Abstract
Objective: To describe fluid resuscitation practices in Brazilian intensive care units and to compare them with those of other countries participating in the Fluid-TRIPS., Methods: This was a prospective, international, cross-sectional, observational study in a convenience sample of intensive care units in 27 countries (including Brazil) using the Fluid-TRIPS database compiled in 2014. We described the patterns of fluid resuscitation use in Brazil compared with those in other countries and identified the factors associated with fluid choice., Results: On the study day, 3,214 patients in Brazil and 3,493 patients in other countries were included, of whom 16.1% and 26.8% (p < 0.001) received fluids, respectively. The main indication for fluid resuscitation was impaired perfusion and/or low cardiac output (Brazil: 71.7% versus other countries: 56.4%, p < 0.001). In Brazil, the percentage of patients receiving crystalloid solutions was higher (97.7% versus 76.8%, p < 0.001), and 0.9% sodium chloride was the most commonly used crystalloid (62.5% versus 27.1%, p < 0.001). The multivariable analysis suggested that the albumin levels were associated with the use of both crystalloids and colloids, whereas the type of fluid prescriber was associated with crystalloid use only., Conclusion: Our results suggest that crystalloids are more frequently used than colloids for fluid resuscitation in Brazil, and this discrepancy in frequencies is higher than that in other countries. Sodium chloride (0.9%) was the crystalloid most commonly prescribed. Serum albumin levels and the type of fluid prescriber were the factors associated with the choice of crystalloids or colloids for fluid resuscitation.
- Published
- 2021
- Full Text
- View/download PDF
29. Stent evaluation by coronary computed tomography angiography: a comparison between Iopamidol-370 and Ioversol-320 hypo-osmolar iodine concentration contrasts.
- Author
-
Garcia AM, Assunção-Jr AN, Dantas-Jr RN, Parga JR, and Ganem F
- Subjects
- Angina, Stable therapy, Artifacts, Cardiac Complexes, Premature, Computed Tomography Angiography adverse effects, Computed Tomography Angiography standards, Coronary Angiography adverse effects, Coronary Angiography standards, Double-Blind Method, Female, Heart Rate, Humans, Male, Middle Aged, Multivariate Analysis, Prohibitins, Prospective Studies, Angina, Stable diagnostic imaging, Computed Tomography Angiography methods, Contrast Media, Coronary Angiography methods, Iopamidol, Stents statistics & numerical data, Triiodobenzoic Acids
- Abstract
Objective: Qualitative and quantitative image analysis between Iopamidol-370 and Ioversol-320 in stents´ evaluation by coronary computed tomography angiography (CTA)., Methods: Sixty-five patients with low-risk stable angina undergoing stent follow-up with coronary CTA were assigned to Iopamidol I-370 ( n = 33) or Ioversol I-320 ( n = 32) in this prospective, double-blind, non-inferiority, randomized trial. Stent lumen image quality was graded by 5-point Likert Scale. Lumen mean attenuation was measured at native coronary segments: pre-stent, post-stent, distal segments and at coronary plaques. Lumen attenuation increase (LAI) ratio was calculated for all stents. Heart rate (HR) variation, premature heart beats (PHB), heat sensation (HS), blooming and beam hardening were also assessed., Results: Image quality was similar between groups, with no significant difference (Likert score 4.48 ± 0.75 vs 4.54 ± 0.65, p = 0.5). There were similarities in LAI ratio between I-370 and I-320 (0.39 ± 0.42 vs 0.48 ± 0.44 HU, p = 0.08). Regarding lumen mean attenuation at native coronary segments, a significant difference was observed, with I-320 presenting lower values, including contrast mean attenuation in distal segments. After statistical multivariate analysis, three variables correlated with stent image quality: 1) stent diameter, 2) HR variation and 3) stent lumen LAI ratio., Conclusions: There was no significant difference between Iopamidol-370 mgI ml
-1 and Ioversol-320 mgI ml-1 contrasts regarding overall stent lumen image quality, which was mainly influenced by stent diameter, HR and LAI ratio. Advances in knowledge: Coronary CTA allows adequate stents' visualization and image quality is influenced by stent diameter, HR variation and LAI ratio.Stents' image quality showed no difference between different concentration contrasts (I-370 vs. I-320); however, higher concentration contrasts may provide an improved overall visualization, especially regarding coronary distal segments.- Published
- 2020
- Full Text
- View/download PDF
30. A model to predict SARS-CoV-2 infection based on the first three-month surveillance data in Brazil.
- Author
-
Diaz-Quijano FA, da Silva JMN, Ganem F, Oliveira S, Vesga-Varela AL, and Croda J
- Subjects
- Adult, Area Under Curve, Brazil, Coronavirus Infections, Female, Humans, Male, Middle Aged, Pandemics, ROC Curve, Reproducibility of Results, SARS-CoV-2, Sensitivity and Specificity, COVID-19 diagnosis, Models, Biological, Population Surveillance
- Abstract
Objective: COVID-19 diagnosis is a critical problem, mainly due to the lack or delay in the test results. We aimed to obtain a model to predict SARS-CoV-2 infection in suspected patients reported to the Brazilian surveillance system., Methods: We analysed suspected patients reported to the National Surveillance System that corresponded to the following case definition: patients with respiratory symptoms and fever, who travelled to regions with local or community transmission or who had close contact with a suspected or confirmed case. Based on variables routinely collected, we obtained a multiple model using logistic regression. The area under the receiver operating characteristic curve (AUC) and accuracy indicators were used for validation., Results: We described 1468 COVID-19 cases (confirmed by RT-PCR) and 4271 patients with other illnesses. With a data subset including 80% of patients from Sao Paulo (SP) and Rio Janeiro (RJ), we obtained a function which reached an AUC of 95.54% (95% CI: 94.41-96.67%) for the diagnosis of COVID-19 and accuracy of 90.1% (sensitivity 87.62% and specificity 92.02%). In a validation dataset including the other 20% of patients from SP and RJ, this model exhibited an AUC of 95.01% (92.51-97.5%) and accuracy of 89.47% (sensitivity 87.32% and specificity 91.36%)., Conclusion: We obtained a model suitable for the clinical diagnosis of COVID-19 based on routinely collected surveillance data. Applications of this tool include early identification for specific treatment and isolation, rational use of laboratory tests, and input for modelling epidemiological trends., (© 2020 John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
31. Imputation method to reduce undetected severe acute respiratory infection cases during the coronavirus disease outbreak in Brazil.
- Author
-
Oliveira SB, Ganem F, Araújo WN, Casabona J, Sanchez MN, and Croda J
- Subjects
- Algorithms, Brazil epidemiology, COVID-19, Humans, Pandemics, Coronavirus Infections epidemiology, Disease Outbreaks, Pneumonia, Viral epidemiology, Public Health Surveillance methods
- Abstract
Introduction: The coronavirus disease (COVD-19) outbreak has overburdened the surveillance of severe acute respiratory infections (SARIs), including the laboratory network. This study was aimed at correcting the absence of laboratory results of reported SARI deaths., Methods: The imputation method was applied for SARI deaths without laboratory information using clinico-epidemiological characteristics., Results: Of 84,449 SARI deaths, 51% were confirmed with COVID-19 while 3% with other viral respiratory diseases. After the imputation method, 95% of deaths were reclassified as COVID-19 while 5% as other viral respiratory diseases., Conclusions: The imputation method was a useful and robust solution (sensitivity and positive predictive value of 98%) for missing values through clinical & epidemiological characteristics.
- Published
- 2020
- Full Text
- View/download PDF
32. Predicting Hospital Admission and Prolonged Length of Stay in Older Adults in the Emergency Department: The PRO-AGE Scoring System.
- Author
-
Curiati PK, Gil-Junior LA, Morinaga CV, Ganem F, Curiati JAE, and Avelino-Silva TJ
- Subjects
- Age Factors, Aged, Aged, 80 and over, Brazil, Cohort Studies, Female, Health Services for the Aged, Humans, Logistic Models, Male, Models, Theoretical, Predictive Value of Tests, Retrospective Studies, Sex Factors, Emergency Service, Hospital statistics & numerical data, Geriatric Assessment, Length of Stay
- Abstract
Study Objective: We developed prediction models for hospital admission and prolonged length of stay in older adults admitted from the emergency department (ED)., Methods: This was a retrospective cohort study of patients aged 70 years or older who visited a geriatric ED in Brazil (N=5,025 visits). We randomly allocated participants to derivation and validation samples in a 2:1 ratio. We then selected 21 variables based on their clinical relevance and generated models to predict the following outcomes: hospital admission and prolonged length of stay, defined as the upper tertile of hospital stay. We used backward stepwise logistic regressions to select our final predictors and developed risk scoring systems based on the relative values of their β coefficients., Results: Overall, 57% of the participants were women, 31% were hospitalized, and 1% died in the hospital. The upper tertile of hospital stay was greater than 7 days. Hospital admission was best predicted by a model including male sex, aged 90 years or older, hospitalization in the previous 6 months, weight loss greater than or equal to 5% in the previous year, acute mental alteration, and acute functional decline. The prediction of prolonged length of stay retained the same variables, except male sex, which was substituted for fatigue. The final scoring system reached areas under the receiver operating characteristic curve of 0.74 for hospital admission and 0.79 for prolonged length of stay, and their accuracies were confirmed in the validation models., Conclusion: The PRO-AGE scoring system predicted hospital admission and prolonged length of stay in older adults with good accuracy, using a simple approach and only 7 easily obtained clinical variables., (Copyright © 2020 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
33. The Other Side of the Coin: Risks of Media Discussions of Scientific Medical Data During the COVID-19 Pandemic.
- Author
-
Fernandes CJ, Ganem F, Olivieri FG, Vilibor MF, and Helito AS
- Subjects
- Betacoronavirus, COVID-19, Humans, SARS-CoV-2, Biomedical Research trends, Coronavirus Infections, Mass Media, Pandemics, Pneumonia, Viral
- Published
- 2020
- Full Text
- View/download PDF
34. Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil.
- Author
-
de Souza WM, Buss LF, Candido DDS, Carrera JP, Li S, Zarebski AE, Pereira RHM, Prete CA Jr, de Souza-Santos AA, Parag KV, Belotti MCTD, Vincenti-Gonzalez MF, Messina J, da Silva Sales FC, Andrade PDS, Nascimento VH, Ghilardi F, Abade L, Gutierrez B, Kraemer MUG, Braga CKV, Aguiar RS, Alexander N, Mayaud P, Brady OJ, Marcilio I, Gouveia N, Li G, Tami A, de Oliveira SB, Porto VBG, Ganem F, de Almeida WAF, Fantinato FFST, Macário EM, de Oliveira WK, Nogueira ML, Pybus OG, Wu CH, Croda J, Sabino EC, and Faria NR
- Subjects
- Adult, Aged, Brazil epidemiology, COVID-19, COVID-19 Testing, Child, Clinical Laboratory Techniques methods, Clinical Laboratory Techniques statistics & numerical data, Coinfection epidemiology, Female, Hospitalization statistics & numerical data, Humans, Infant, Male, Mortality, SARS-CoV-2, Socioeconomic Factors, COVID-19 Drug Treatment, Betacoronavirus isolation & purification, Coronavirus Infections diagnosis, Coronavirus Infections drug therapy, Coronavirus Infections mortality, Coronavirus Infections therapy, Coronavirus Infections transmission, Disease Transmission, Infectious prevention & control, Disease Transmission, Infectious statistics & numerical data, Influenza, Human diagnosis, Influenza, Human epidemiology, Influenza, Human virology, Pandemics, Pneumonia, Viral diagnosis, Pneumonia, Viral mortality, Pneumonia, Viral therapy, Pneumonia, Viral transmission
- Abstract
The first case of COVID-19 was detected in Brazil on 25 February 2020. We report and contextualize epidemiological, demographic and clinical findings for COVID-19 cases during the first 3 months of the epidemic. By 31 May 2020, 514,200 COVID-19 cases, including 29,314 deaths, had been reported in 75.3% (4,196 of 5,570) of municipalities across all five administrative regions of Brazil. The R
0 value for Brazil was estimated at 3.1 (95% Bayesian credible interval = 2.4-5.5), with a higher median but overlapping credible intervals compared with some other seriously affected countries. A positive association between higher per-capita income and COVID-19 diagnosis was identified. Furthermore, the severe acute respiratory infection cases with unknown aetiology were associated with lower per-capita income. Co-circulation of six respiratory viruses was detected but at very low levels. These findings provide a comprehensive description of the ongoing COVID-19 epidemic in Brazil and may help to guide subsequent measures to control virus transmission.- Published
- 2020
- Full Text
- View/download PDF
35. Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade Brasileira de Cardiologia - 2019.
- Author
-
Bernoche C, Timerman S, Polastri TF, Giannetti NS, Siqueira AWDS, Piscopo A, Soeiro AM, Reis AGADC, Tanaka ACS, Thomaz AM, Quilici AP, Catarino AH, Ribeiro ACL, Barreto ACP, Azevedo Filho AFB, Pazin Filho A, Timerman A, Scarpa BR, Timerman B, Tavares CAM, Martins CSL, Serrano Junior CV, Malaque CMS, Pisani CF, Batista DV, Leandro DLF, Szpilman D, Gonçalves DM, Paiva EF, Osawa EA, Lima EG, Adam EL, Peixoto E, Evaristo EF, Azeka E, Silva FBD, Wen FH, Ferreira FG, Lima FG, Fernandes FL, Ganem F, Galas FRBG, Tarasoutchi F, Souza GEC, Feitosa Filho GS, Foronda G, Guimarães HP, Abud ICK, Leite ISL, Linhares Filho JPP, Moraes Junior JBMX, Falcão JLAA, Ramires JAF, Cavalini JF, Saraiva JFK, Abrão KC, Pinto LF, Bianchi LLT, Lopes LNGD, Piegas LS, Kopel L, Godoy LC, Tobase L, Hajjar LA, Dallan LAP, Caneo LF, Cardoso LF, Canesin MF, Park M, Rabelo MMN, Malachias MVB, Gonçalves MAB, Almeida MFB, Souza MFS, Favarato MHS, Carrion MJM, Gonzalez MM, Bortolotto MRFL, Macatrão-Costa MF, Shimoda MS, Oliveira-Junior MT, Ikari NM, Dutra OP, Berwanger O, Pinheiro PAPC, Reis PFFD, Cellia PHM, Santos Filho RDD, Gianotto-Oliveira R, Kalil Filho R, Guinsburg R, Managini S, Lage SHG, Yeu SP, Franchi SM, Shimoda-Sakano T, Accorsi TD, Leal TCA, Guimarães V, Sallai VS, Ávila WS, and Sako YK
- Subjects
- Brazil, Cardiology, Humans, Risk Assessment, Risk Factors, Societies, Medical standards, Treatment Outcome, Cardiopulmonary Resuscitation standards, Cardiovascular Diseases diagnosis, Cardiovascular Diseases therapy, Emergency Medical Services standards
- Published
- 2019
- Full Text
- View/download PDF
36. Successive blood pressure measurements to evaluate suspected and treated hypertension.
- Author
-
Vieira da Silva MA, Mendes da Silva AP, Artigas Giorgi DM, and Ganem F
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Hypertension therapy, Male, Middle Aged, Blood Pressure, Blood Pressure Monitoring, Ambulatory, Hypertension diagnosis, Hypertension physiopathology
- Abstract
Introduction: According to the published literature, blood pressure (BP) measurements performed in the outpatient clinical setting are often inaccurate. The white coat effect and improper technique are the main causes of this imprecision. Construction of a set of readings without them could improve the accuracy of BP measurement., Objective: To evaluate the accuracy and agreement of successive office BP measurements using the awake blood pressure average (ABPa) as the gold standard., Methods: BP was measured in 852 patients using three techniques: in office (OBPa); seven successive measurements performed by a nurse using an automatic device; and 24 h of ambulatory BP monitoring. BP averages (BPa) were obtained from the nurse's measurements: 1-2BPa (first and second), 3-7BPa (third to seventh), and 1-7BPa (first to seventh). OBPa and successive measurements were tested against ABPa by calculating the following: average difference in BP of 1-2BPa, 3-7BPa and OBPa, and the area under the curve., Results: Among the 834 patients eligible, 374 (43.9%) were considered to be hypertensive on the basis of the ABPa (≥135/85 mmHg). 3-7BPa showed the lowest average difference (4/3 mmHg). By contrast, OBPa showed the highest result (21/11 mmHg). The mean difference with 1-2BPa was 8/4 mmHg. The areas under the curve were better with 3-7BPa (0.82-0.85) and 1-2BPa (0.82-0.83) than OBPa (0.67-0.71) for both systolic and diastolic BP., Conclusion: All means from successive measurements showed a better precision than OBPa, even the two first readings. However, more research needs to be carried out before recommendation of the use of this technique in routine practice.
- Published
- 2016
- Full Text
- View/download PDF
37. Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina.
- Author
-
Piñero F, Marciano S, Anders M, Orozco Ganem F, Zerega A, Cagliani J, Andriani O, de Santibañes E, Gil O, Podestá LG, McCormack L, Gadano A, and Silva M
- Subjects
- Aged, Area Under Curve, Argentina, Carcinoma, Hepatocellular blood, Carcinoma, Hepatocellular mortality, Carcinoma, Hepatocellular pathology, Disease-Free Survival, Female, Humans, Kaplan-Meier Estimate, Liver Neoplasms blood, Liver Neoplasms mortality, Liver Neoplasms pathology, Liver Transplantation mortality, Male, Middle Aged, Multivariate Analysis, Neoplasm Staging, Predictive Value of Tests, Proportional Hazards Models, ROC Curve, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, alpha-Fetoproteins analysis, Carcinoma, Hepatocellular surgery, Decision Support Techniques, Liver Neoplasms surgery, Liver Transplantation adverse effects, Neoplasm Recurrence, Local
- Abstract
Background and Aim: The Up-to-7 criteria on the basis of the explanted liver features categorize patients at higher risk of hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT). The aim of this study was to propose a novel pretransplant scoring system to predict recurrence including pre-LT data., Patients and Methods: From 763 consecutive adult patients who underwent transplantation in four LT centers from Argentina, 124 patients with HCC were included. A scoring system was developed in 87 patients from pre-LT risk factors for recurrence as determined by hazard ratios (HRs) from a multivariate Cox regression analysis., Results: Overall survival and recurrence rates at 5 years were 63.3 and 13.7%, respectively, during a follow-up period of 3.5±2.2 years. Variables associated with HCC recurrence on multivariate analysis were α-fetoprotein more than 100 ng/ml (HR=5.6, P=0.001) and tumor beyond Up-to-7 imaging criteria (HR=6.3, P=0.001). Bootstrap validation showed that overfitting was negligible. Scoring points were assigned as follows (0-2 points): pre-LT α-fetoprotein more than 100 ng/ml (presence=1 point, absence=0 point), and tumor beyond Up-to-7 imaging criteria (presence=1 point, absence=0 point). AUROC curve indicated a c-statistic of 0.74 (0.58-0.88, P=0.003). Two distinct subgroups of patients were identified with a cut-off more than or equal to 1 point (62% sensitivity and 82% specificity): low risk (0 point) and high risk (1-2 points). The 5-year recurrence rate was 9.4 and 44.5% (P=0.0001) and the 5-year overall survival was 78.1 and 34.8% (P=0.0001) in the low-risk and high-risk groups, respectively., Conclusion: This scoring model may be a useful additional tool for HCC recurrence risk stratification before LT. Prospective studies are needed to evaluate our model.
- Published
- 2016
- Full Text
- View/download PDF
38. Influence of proven oral therapies in the very old with acute coronary syndromes: A 15 year experience.
- Author
-
Nicolau JC, Franci A, Barbosa CJ, Baracioli LM, Franken M, Furtado RH, Giraldez RR, Ganem F, Lima FG, Menezes FR, Arantes FB, Ramires JA, Filho RK, and Giugliano RP
- Subjects
- Acute Coronary Syndrome diagnosis, Administration, Oral, Adult, Age Factors, Aged, Aged, 80 and over, Humans, Middle Aged, Mortality trends, Prospective Studies, Time Factors, Acute Coronary Syndrome drug therapy, Acute Coronary Syndrome mortality, Anticoagulants administration & dosage, Platelet Aggregation Inhibitors administration & dosage
- Published
- 2015
- Full Text
- View/download PDF
39. Disseminating cardiopulmonary resuscitation training by distributing 9,200 personal manikins.
- Author
-
de Paiva EF, Padilha Rde Q, Sgobero JK, Ganem F, and Cardoso LF
- Subjects
- Adolescent, Adult, Brazil, Child, Community Health Workers, Education, Nonprofessional organization & administration, Faculty, Female, Heart Arrest diagnosis, Humans, Male, Prospective Studies, Schools, Students, Cardiopulmonary Resuscitation education, Education, Nonprofessional methods, Heart Arrest therapy, Manikins
- Abstract
Objectives: Community members should be trained so that witnesses of cardiac arrests are able to trigger the emergency system and perform adequate resuscitation. In this study, the authors evaluated the results of cardiopulmonary resuscitation (CPR) training of communities in four Brazilian cities, using personal resuscitation manikins., Methods: In total, 9,200 manikins were distributed in Apucarana, Itanhaém, Maringá, and São Carlos, which are cities where the populations range from 80,000 to 325,000 inhabitants. Elementary and secondary school teachers were trained on how to identify a cardiac arrest, trigger the emergency system, and perform chest compressions. The teachers were to transfer the training to their students, who would then train their families and friends., Results: In total, 49,131 individuals were trained (6.7% of the population), but the original strategy of using teachers and students as multipliers was responsible for only 27.9% of the training. A total of 508 teachers were trained, and only 88 (17.3%) transferred the training to the students. Furthermore, the students have trained only 45 individuals of the population. In Maringá and São Carlos, the strategy was changed and professionals in the primary health care system were prepared and used as multipliers. This strategy proved extremely effective, especially in Maringá, where 39,041 individuals were trained (79.5% of the total number of trainings). Community health care providers were more effective in passing the training to students than the teachers (odds ratio [OR] = 7.12; 95% confidence interval [CI] = 4.74 to 10.69; p < 0.0001)., Conclusions: Instruction of CPR using personal manikins by professionals in the primary health care system seems to be a more efficient strategy for training the community than creating a training network in the schools., (© 2014 by the Society for Academic Emergency Medicine.)
- Published
- 2014
- Full Text
- View/download PDF
40. [Guidelines of Sociedade Brasileira de Cardiologia for Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction (II Edition, 2007) 2013-2014 Update].
- Author
-
Nicolau JC, Timerman A, Marin-Neto JA, Piegas LS, Barbosa CJ, Franci A, Avezum A Jr, Carvalho AC, Markman Filho B, Polanczyk CA, Rochitte CE, Serrano Júnior CV, Precoma DB, Silva Junior DG, Albuquerque DC, Stefanini E, Knobel E, Jatene FB, Feres F, Morcerf FA, Ganem F, Lima Filho FA, Feitosa Filho GS, Ferreira JF, Meneghetti JC, Saraiva JF, Silva LS, Maia LN, Baracioli LM, Lisboa LA, Dallan LA, Bodanese LC, Andrade MD, Oliveira Júnior M, Dutra OP, Coelho OR, Leães PE, Albuquerque PF, Lemos P, Kalil R, Costa RV, Esporcate R, Marino RL, Botellho RV, Meneghelo RS, Sprovieri SR, Timerman S, and Mathias Júnior W
- Subjects
- Cardiovascular Diseases prevention & control, Depression prevention & control, Humans, Hyperlipidemias prevention & control, Obesity prevention & control, Risk Assessment, Smoking Prevention, Stress, Psychological prevention & control, Angina, Unstable prevention & control, Angina, Unstable rehabilitation, Myocardial Infarction prevention & control, Myocardial Infarction rehabilitation
- Published
- 2014
- Full Text
- View/download PDF
41. The bleeding risk score as a mortality predictor in patients with acute coronary syndrome.
- Author
-
Nicolau JC, Moreira HG, Baracioli LM, Serrano CV Jr, Lima FG, Franken M, Giraldez RR, Ganem F, Kalil Filho R, Ramires JA, and Mehran R
- Subjects
- Acute Coronary Syndrome complications, Adult, Aged, Angioplasty, Brazil epidemiology, Female, Fibrinolytic Agents administration & dosage, Hemorrhage complications, Humans, Male, Middle Aged, Myocardial Infarction drug therapy, ROC Curve, Retrospective Studies, Risk Assessment, Acute Coronary Syndrome mortality, Hemorrhage mortality, Hospital Mortality, Myocardial Infarction mortality
- Abstract
Background: It is well known that the occurrence of bleeding increases in-hospital mortality in patients with acute coronary syndromes (ACS), and there is a good correlation between bleeding risk scores and bleeding incidence. However, the role of bleeding risk score as mortality predictor is poorly studied., Objective: The main purpose of this paper was to analyze the role of bleeding risk score as in-hospital mortality predictor in a cohort of patients with ACS treated in a single cardiology tertiary center., Methods: Out of 1655 patients with ACS (547 with ST-elevation ACS and 1118 with non-ST-elevation ACS), we calculated the ACUITY/HORIZONS bleeding score prospectively in 249 patients and retrospectively in the remaining 1416. Mortality information and hemorrhagic complications were also obtained., Results: Among the mean age of 64.3 ± 12.6 years, the mean bleeding score was 18 ± 7.7. The correlation between bleeding and mortality was highly significant (p < 0.001, OR = 5.296), as well as the correlation between bleeding score and in-hospital bleeding (p < 0.001, OR = 1.058), and between bleeding score and in-hospital mortality (adjusted OR = 1.121, p < 0.001, area under the ROC curve 0.753, p < 0.001). The adjusted OR and area under the ROC curve for the population with ST-elevation ACS were, respectively, 1.046 (p = 0.046) and 0.686 ± 0.040 (p < 0.001); for non-ST-elevation ACS the figures were, respectively, 1.150 (p < 0.001) and 0.769 ± 0.036 (p < 0.001)., Conclusions: Bleeding risk score is a very useful and highly reliable predictor of in-hospital mortality in a wide range of patients with acute coronary syndromes, especially in those with unstable angina or non-ST-elevation acute myocardial infarction.
- Published
- 2013
- Full Text
- View/download PDF
42. [Brazilian guidelines on platelet antiaggregants and anticoagulants in cardiology].
- Author
-
Lorga Filho AM, Azmus AD, Soeiro AM, Quadros AS, Avezum A Jr, Marques AC, Franci A, Manica AL, Volschan A, De Paola AA, Greco AI, Ferreira AC, Sousa AC, Pesaro AE, Simão AF, Lopes AS, Timerman A, Ramos AI, Alves BR, Caramelli B, Mendes BA, Polanczyk CA, Montenegro CE, Barbosa CJ, Serrano CV Jr, Melo CC, Pinho C, Moreira DA, Calderaro D, Gualandro DM, Armaganijan D, Machado Neto EA, Bocchi EA, Paiva EF, Stefanini E, D'Amico E, Evaristo EF, Silva EE, Fernandes F, Brito FS Jr, Bacal F, Ganem F, Gomes FL, Mattos FR, Moraes Neto FR, Tarasoutchi F, Darrieux FC, Feitosa GS, Fenelon G, Morais GR, Correa Filho H, Castro I, Gonçalves I Jr, Atié J, Souza Neto JD, Ferreira JF, Nicolau JC, Faria Neto JR, Annichino-Bizzacchi JM, Zimerman LI, Piegas LS, Pires LJ, Baracioli LM, Silva LB, Mattos LA, Lisboa LA, Magalhães LP, Lopes MA, Montera MW, Figueiredo MJ, Malachias MV, Gaz MV, Andrade MD, Bacellar MS, Barbosa MR, Clausell NO, Dutra OP, Coelho OR, Yu PC, Lavítola PL, Lemos Neto PA, Andrade PB, Farsky PS, Franco RA, Kalil RA, Lopes RD, Esporcatte R, Heinisch RH, Kalil Filho R, Giraldez RR, Alves RC, Leite RE, Gagliardi RJ, Ramos RF, Montenegro ST, Accorsi TA, Jardim TS, Scudeler TL, Moisés VA, and Portal VL
- Subjects
- Acute Coronary Syndrome drug therapy, Atrial Fibrillation drug therapy, Brazil, Chagas Disease drug therapy, Female, Heart Failure drug therapy, Humans, Ischemic Attack, Transient drug therapy, Myocardial Infarction drug therapy, Perioperative Period, Societies, Medical, Stroke drug therapy, Venous Thromboembolism drug therapy, Anticoagulants therapeutic use, Cardiovascular Diseases drug therapy, Platelet Aggregation Inhibitors therapeutic use
- Published
- 2013
- Full Text
- View/download PDF
43. Clinical characteristics and long-term outcome of patients with acute coronary syndromes and Takayasu arteritis.
- Author
-
Soeiro Ade M, Almeida MC, Torres TA, Franken M, Lima FG, Ganem F, Giraldez RR, Baracioli L, Tavares MO Jr, Serrano CV Jr, and Nicolau JC
- Subjects
- Acute Coronary Syndrome complications, Adult, Female, Humans, Middle Aged, Retrospective Studies, Takayasu Arteritis complications, Time Factors, Treatment Outcome, Acute Coronary Syndrome diagnosis, Acute Coronary Syndrome therapy, Takayasu Arteritis diagnosis, Takayasu Arteritis therapy
- Abstract
Introduction: Monitoring of disease activity and the best therapeutic approach are a challenge in Takayasu arteritis (TA). When associated with acute coronary syndromes (ACS), the best interventional treatment has not been established. The objective of this study was to describe the baseline characteristics, clinical manifestations, treatment and long-term outcome of patients with TA and ACS., Methods: We retrospectively analyzed eight patients between 2004 and 2010. The following data were obtained: age, gender, clinical and electrocardiographic manifestations, Killip class, risk factors for ACS, markers of myocardial necrosis (CK-MB and troponin), creatinine clearance, left ventricular ejection fraction, inflammatory markers (C-reactive protein and erythrocyte sedimentation rate [ESR]), medication during hospital stay, angiographic findings, treatment (medical, percutaneous or surgical) and long-term outcome. Statistical data were expressed as percentages and absolute values., Results: All eight patients were women, median age 49 years. Typical chest pain was present in 37.5%. Elevated ESR was observed in 85.7%. Three patients underwent coronary artery bypass grafting, three underwent percutaneous coronary angioplasty (two with bare-metal stents and one with a drug-eluting stent) and two were treated medically. In-hospital mortality was 25%. There were no deaths during a mean follow-up of 30 months., Conclusions: In our study, patients who were discharged home had good outcomes in long-term follow-up with medical, percutaneous or surgical treatment. ESR appears to be associated with ACS in TA., (Copyright © 2012 Sociedade Portuguesa de Cardiologia. Published by Elsevier España. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
44. Rare manifestation of acute pulmonary edema associated with acute lupus myocarditis.
- Author
-
Soeiro Ade M, Bergamin FS, Almeida MC, Serrano CV Jr, Falcão BA, and Ganem F
- Subjects
- Female, Humans, Lupus Erythematosus, Systemic diagnosis, Myocarditis diagnostic imaging, Pulmonary Edema diagnostic imaging, Radiography, Young Adult, Lupus Erythematosus, Systemic complications, Myocarditis etiology, Pulmonary Edema etiology
- Abstract
Systemic Lupus Erythematosus (SLE) is the most common systemic autoimmune disease, occurring more frequently in women, usually aged between 16 and 55 years 1, 2. Although classically the kidneys are the organs most affected in SLE, cardiopulmonary circulation and the heart may also be affected significantly 3. In this context, the occurrence of acute pulmonary edema associated with lupus myocarditis is rare and specific immunosuppressive therapy remains unclear.
- Published
- 2012
- Full Text
- View/download PDF
45. Preoperative B-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery.
- Author
-
Ganem F, Serrano CV Jr, Fernandes JL, Blotta MH, Souza JA, Nicolau JC, Ramires JA, and Hueb WA
- Subjects
- Acrylamides blood, Aged, Biomarkers blood, Brazil, C-Reactive Protein metabolism, Cardiac Surgical Procedures mortality, Cardiopulmonary Bypass adverse effects, Cardiotonic Agents therapeutic use, Chi-Square Distribution, Dobutamine therapeutic use, Female, Hospital Mortality, Humans, Inflammation blood, Inflammation mortality, Intensive Care Units, Interleukin-6 blood, Interleukin-8 blood, Intra-Aortic Balloon Pumping, Length of Stay, Male, Middle Aged, P-Selectin blood, Postoperative Complications blood, Postoperative Complications mortality, Postoperative Complications therapy, ROC Curve, Respiration, Artificial, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, beta-Alanine analogs & derivatives, beta-Alanine blood, Cardiac Surgical Procedures adverse effects, Inflammation complications, Inflammation Mediators blood, Natriuretic Peptide, Brain blood, Postoperative Complications etiology
- Abstract
Objectives: B-type natriuretic peptide (BNP) and inflammatory markers are implicated in the pathophysiology of both ischemic cardiomyopathy and complications after cardiac surgery with cardiopulmonary bypass (CPB). The purpose of this study was to assess preoperative and postoperative levels of BNP, interleukin-6 (IL-6), interleukin-8 (IL-8), P-selectin, intercellular adhesion molecule (ICAM), C-reactive protein (CRP) in patients undergoing cardiac surgery with CPB and investigate their variation and ability to correlate with immediate outcome., Methods: Plasma levels of these markers were measured preoperatively, 6 and 24 h after CBP in 62 patients. Main endpoints were requirements for intra-aortic balloon pump, intensive care unit (ICU) stay longer than five days, ventilator dependence >24 h, requirement for dobutamine, hospital stay >10 days, clinical complications (infection, myocardial infarction, renal failure, stroke and ventricular arrhythmias) and in-hospital mortality., Results: Preoperative BNP levels correlate with longer ICU stay (P = 0.003), longer ventilator use (P = 0.018) and duration of dobutamine use (P < 0.001). The receiver-operating characteristic curve demonstrated BNP levels >190 pg/ml as predictor of ICU >5 days and BNP levels >20.5 pg/ml correlated with dobutamine use, with areas under the curve of 0.712 and 0.842, respectively. Preoperative levels of ICAM-1 were associated with in-hospital mortality (P = 0.042). In the postoperative period, was found association between CRP, IL-6 and P-selectin with ventilation duration (P = 0.013, P = 0.006, P < 0.001, respectively) and P-selectin with ICU stay (P = 0.009)., Conclusions: BNP correlates with clinical endpoints more than inflammatory markers and can be used as a predictor of early outcome after heart surgery.
- Published
- 2011
- Full Text
- View/download PDF
46. The influence of health insurance plans on the long term outcome of patients with acute myocardial infarction.
- Author
-
Nicolau JC, Baracioli LM, Serrano CV Jr, Giraldez RR, Kalil Filho R, Lima FG, Franken M, Ganem F, Lage RL, and Truffa R
- Subjects
- Brazil epidemiology, Epidemiologic Methods, Female, Hospital Mortality, Humans, Male, Middle Aged, Myocardial Infarction diagnosis, Myocardial Infarction therapy, Patient Discharge, Prognosis, Treatment Outcome, Insurance, Health, Myocardial Infarction mortality, National Health Programs
- Abstract
Background: Little is known, especially in our country, about the influence of health insurance plans on the long term outcome of patients after acute myocardial infarction (AMI)., Objective: To assess the outcome of patients with AMI who are covered by the National Health System (SUS) or other health insurance plans., Methods: We analyzed 1,588 patients with AMI (mean age of 63.3 + 12.9 years, 71.7% male) who were included prospectively into a specific database and followed up for up to 7.55 years. Of this total, 1,003 were placed in the "SUS" group and 585 in the "other insurance plans" group. We applied chi-square, log-rank and Cox (stepwise) to the different statistical analyses. The long term multivariate model with mortality as a dependent variable included 18 independent variables., Results: In-hospital mortality rates in the "other insurance plans" and "SUS" groups were 11.4% and 10.3%, respectively (p = 0.5); in the long term, survival chances in the groups were respectively, 70.4% + 2.9 and 56.4% + 4.0 (p = 0.001, hazard-ratio = 1.43, or a 43% higher chance of death in the "SUS" group). In the adjusted model, the 'SUS' group had a significantly higher chance of death (a 36% higher chance, p = 0.005). Surgical revascularization and angioplasty improved the prognosis of these patients, whereas age and previous history of infarction, diabetes or heart failure worsened the prognosis., Conclusions: Relative to patients with other insurance plans, SUS users present similar mortality rates during hospital stay, but their prognosis is worse in the long term, thus reinforcing the need for additional efforts to improve the care provided to these patients after hospital discharge.
- Published
- 2008
- Full Text
- View/download PDF
47. Local intraarterial fibrinolysis in the carotid territory.
- Author
-
Theron J, Courtheoux P, Casasco A, Alachkar F, Notari F, Ganem F, and Maiza D
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Fibrinolytic Agents therapeutic use, Humans, Injections, Intra-Arterial, Male, Middle Aged, Streptokinase administration & dosage, Streptokinase therapeutic use, Urokinase-Type Plasminogen Activator administration & dosage, Urokinase-Type Plasminogen Activator therapeutic use, Arterial Occlusive Diseases drug therapy, Carotid Artery Diseases drug therapy, Cerebral Arterial Diseases drug therapy, Fibrinolytic Agents administration & dosage
- Abstract
A series comprising 12 patients who had intraarterial local fibrinolysis in the carotid territory is reported. A classification is proposed that divides the different types of occlusions into three groups on the basis of angiographic location. Group 1 (two cases) comprises occlusion of the extra- and/or intracranial carotid artery with patency of the circle of Willis and the lenticulostriate arteries. In this group, there is no brain infarction, the CT findings are normal, and the clinical signs are mainly hemodynamic and intermittent. Fibrinolysis may be performed late and rather safely and completed by surgery or angioplasty of the neck vessel stenosis responsible for the occlusion. Group 2 (five cases) comprises occlusions of the cortical arteries without involvement of the lenticulostriate arteries. The mechanism of the occlusion can be hemodynamic or embolic. Group 3 (five cases) comprises occlusions of intracerebral arteries involving the lenticulostriate arteries. In groups 2 and 3 with brain infarction, fibrinolysis will only be able to restore viability of the area of cerebral tissue surrounding the infarction (penumbra). The time factor is particularly critical in group 3 because lenticulostriate arteries are terminal vessels whose revascularization may induce hemorrhages with increasing frequency as the occlusion time is prolonged. The time factor is less critical in group 2 because collaterals make the ischemia less severe in the infarcted area and the vital and functional consequences of hemorrhage are not as serious as in group 3 because of the location. In this series, all the symptomatic complications of hemorrhage (two cases) occurred in group 3, in patients treated later than 6 hr after clinical onset. Given the time delay inherent in performing CT and angiography and in making the medical decision, it is considered dangerous to undertake fibrinolytic therapy in group 3, unless it can be started before 4 or 5 hr after clinical onset.
- Published
- 1989
48. [Sciatica caused by arachnoid cyst].
- Author
-
Benazza A, Khouri S, Guincestre JY, Ganem F, and Houtteville JP
- Subjects
- Female, Humans, Arachnoid, Cysts complications, Sciatica etiology
- Published
- 1989
49. [Diabetic xanthoma].
- Author
-
GANEM F and SPEZIALE HO
- Subjects
- Humans, Diabetes Complications, Lipidoses etiology, Xanthomatosis
- Published
- 1959
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.